1:0:0:0:100:217:393:710:12:g_d0_f1:12:g_d0_f1:?:NBER WORKING PAPER SERIES
1:1:25:100:28:95:516:610:12:g_d0_f1:12:g_d0_f1:?:HOW MUCH FAVORABLE SELECTION IS LEFT IN MEDICARE ADVANTAGE?
1:2:84:28:14:256:355:582:12:g_d0_f1:12:g_d0_f1:?:Joseph P. Newhouse
1:3:102:14:14:279:333:568:12:g_d0_f1:12:g_d0_f1:?:Mary Price
1:4:112:14:14:249:362:554:12:g_d0_f1:12:g_d0_f1:?:J. Michael McWilliams
1:5:133:14:14:283:328:540:12:g_d0_f1:12:g_d0_f1:?:John Hsu
1:6:141:14:28:256:356:526:12:g_d0_f1:12:g_d0_f1:?:Thomas G. McGuire
1:7:158:28:14:253:359:498:12:g_d0_f1:12:g_d0_f1:?:Working Paper 20021
1:8:177:14:42:218:393:484:12:g_d0_f1:12:g_d0_f1:?:http://www.nber.org/papers/w20021
1:9:210:42:14:173:438:442:12:g_d0_f1:12:g_d0_f1:?:NATIONAL BUREAU OF ECONOMIC RESEARCH
1:10:246:14:14:237:374:428:12:g_d0_f1:12:g_d0_f1:?:1050 Massachusetts Avenue
1:11:271:14:14:250:362:414:12:g_d0_f1:12:g_d0_f1:?:Cambridge, MA 02138
1:12:290:14:116:276:334:400:12:g_d0_f1:12:g_d0_f1:?:March 2014
1:13:300:116:14:71:539:284:12:g_d0_f1:12:g_d0_f1:F:The authors are grateful to the National Institute of Aging, Grant # P01 AG032952 for support. Newhouse
1:14:403:14:14:71:539:270:12:g_d0_f1:12:g_d0_f1:F:wishes to disclose that he is a director of Aetna, which sells Medicare Advantage plans as well as Medigap
1:15:509:14:14:71:539:256:12:g_d0_f1:12:g_d0_f1:F:plans. Hsu has consulted for Kaiser Permanente, which sells Medicare Advantage plans, and has consulted
1:16:612:14:14:71:539:242:12:g_d0_f1:12:g_d0_f1:F:for Boston Consulting Group, which has advised Medicare Advantage plans. The views expressed
1:17:704:14:14:71:539:228:12:g_d0_f1:12:g_d0_f1:F:herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic
1:18:811:14:28:71:118:214:12:g_d0_f1:12:g_d0_f1:F:Research.
1:19:820:28:14:71:539:186:12:g_d0_f1:12:g_d0_f1:F:At least one co-author has disclosed a financial relationship of potential relevance for this research.
1:20:923:14:28:71:465:172:12:g_d0_f1:12:g_d0_f1:F:Further information is available online at http://www.nber.org/papers/w20021.ack
1:21:1003:28:14:71:539:144:12:g_d0_f1:12:g_d0_f1:F:NBER working papers are circulated for discussion and comment purposes. They have not been peer-
1:22:1099:14:14:71:539:130:12:g_d0_f1:12:g_d0_f1:F:reviewed or been subject to the review by the NBER Board of Directors that accompanies official
1:23:1194:14:28:71:168:116:12:g_d0_f1:12:g_d0_f1:F:NBER publications.
1:24:1212:28:14:71:539:88:12:g_d0_f1:12:g_d0_f1:F:© 2014 by Joseph P. Newhouse, Mary Price, J. Michael McWilliams, John Hsu, and Thomas G. McGuire.
1:25:1309:14:14:71:539:74:12:g_d0_f1:12:g_d0_f1:F:All rights reserved. Short sections of text, not to exceed two paragraphs, may be quoted without explicit
1:26:1414:14:0:71:447:60:12:g_d0_f1:12:g_d0_f1:F:permission provided that full credit, including © notice, is given to the source.
2:27:1495:0:14:72:381:700:12:g_d0_f1:12:g_d0_f1:F:How Much Favorable Selection Is Left in Medicare Advantage?
2:28:1554:14:14:72:527:686:12:g_d0_f1:12:g_d0_f1:F:Joseph P. Newhouse, Mary Price, J. Michael McWilliams, John Hsu, and Thomas G. McGuire
2:29:1640:14:14:72:234:672:12:g_d0_f1:12:g_d0_f1:F:NBER Working Paper No. 20021
2:30:1668:14:14:72:130:658:12:g_d0_f1:12:g_d0_f1:F:March 2014
2:31:1678:14:28:72:163:644:12:g_d0_f1:12:g_d0_f1:F:JEL No. I1,I13,I18
2:32:1696:28:28:273:338:616:12:Times:12:Times:?:ABSTRACT
2:33:1704:28:14:72:540:588:12:g_d0_f1:12:g_d0_f1:F:There are two types of selection models in the health economics literature.  One focuses on choice
2:34:1802:14:14:72:540:574:12:g_d0_f1:12:g_d0_f1:F:between a fixed set of contracts.  Consumers with greater demand for medical care services prefer
2:35:1899:14:14:72:540:560:12:g_d0_f1:12:g_d0_f1:F:contracts with more generous reimbursement, resulting in a suboptimal proportion of consumers in
2:36:1995:14:14:72:540:546:12:g_d0_f1:12:g_d0_f1:F:such contracts in equilibrium.  In extreme cases more generous contracts may disappear (the “death
2:37:2093:14:14:72:541:532:12:g_d0_f1:12:g_d0_f1:F:spiral”).  In the other model insurers tailor the contracts they offer consumers to attract profitable
2:38:2195:14:28:72:541:518:12:g_d0_f1:12:g_d0_f1:F:consumers. An equilibrium may or may not exist in such models, but if it exists it is not first best.
2:39:2296:28:14:72:540:490:12:g_d0_f1:12:g_d0_f1:F:The Medicare Advantage program offers an opportunity to study these models empirically, although
2:40:2392:14:14:72:540:476:12:g_d0_f1:12:g_d0_f1:F:unlike the models in the economics literature there is a regulator with various tools to address selection.
2:41:2499:14:14:72:540:462:12:g_d0_f1:12:g_d0_f1:F:One such tool is risk adjustment, or making budget neutral transfers among insurers using observable
2:42:2599:14:14:72:540:448:12:g_d0_f1:12:g_d0_f1:F:characteristics of enrollees that predict spending.  Medicare drastically changed its risk adjustment
2:43:2700:14:14:72:540:434:12:g_d0_f1:12:g_d0_f1:F:program starting in 2004 and made a number of other changes to reduce selection as well.  Previous
2:44:2798:14:14:72:540:420:12:g_d0_f1:12:g_d0_f1:F:work has argued that the changes worsened selection.  We show, using a much larger data set, that
2:45:2895:14:42:72:392:406:12:g_d0_f1:12:g_d0_f1:F:this was not the case, but that some inherent selection may remain.
2:46:2962:42:14:72:171:364:12:g_d0_f1:12:g_d0_f1:F:Joseph P. Newhouse
2:47:2980:14:14:72:242:350:12:g_d0_f1:12:g_d0_f1:F:Division of Health Policy Research
2:48:3014:14:14:72:147:336:12:g_d0_f1:12:g_d0_f1:F:  and Education
2:49:3029:14:14:72:165:322:12:g_d0_f1:12:g_d0_f1:F:Harvard University
2:50:3047:14:14:72:185:308:12:g_d0_f1:12:g_d0_f1:F:180 Longwood Avenue
2:51:3066:14:14:72:195:294:12:g_d0_f1:12:g_d0_f1:F:Boston, MA  02115-5899
2:52:3088:14:14:72:124:280:12:g_d0_f1:12:g_d0_f1:F:and NBER
2:53:3096:14:28:72:232:266:12:g_d0_f1:12:g_d0_f1:F:newhouse@hcp.med.harvard.edu
2:54:3124:28:14:72:126:238:12:g_d0_f1:12:g_d0_f1:F:Mary Price
2:55:3134:14:14:72:173:224:12:g_d0_f1:12:g_d0_f1:F:Division of Research
2:56:3154:14:14:72:163:210:12:g_d0_f1:12:g_d0_f1:F:Kaiser Permanente
2:57:3171:14:14:72:167:196:12:g_d0_f1:12:g_d0_f1:F:442 Brimhall Street
2:58:3190:14:14:72:168:182:12:g_d0_f1:12:g_d0_f1:F:St. Paul, MN 55105
2:59:3208:14:28:72:178:168:12:g_d0_f1:12:g_d0_f1:F:price.bdc@gmail.com
2:60:3227:28:14:72:185:140:12:g_d0_f1:12:g_d0_f1:F:J. Michael McWilliams
2:61:3248:14:14:72:165:126:12:g_d0_f1:12:g_d0_f1:F:Harvard University
2:62:3266:14:14:72:185:112:12:g_d0_f1:12:g_d0_f1:F:180 Longwood Avenue
2:63:3285:14:14:72:164:98:12:g_d0_f1:12:g_d0_f1:F:Boston, MA 02115
2:64:3301:14:0:72:240:84:12:g_d0_f1:12:g_d0_f1:F:mcwilliams@hcp.med.harvard.edu
2:65:3331:0:14:306:351:364:12:g_d0_f1:12:g_d0_f1:?:John Hsu
2:66:3339:14:14:306:400:350:12:g_d0_f1:12:g_d0_f1:?:Partners Healthcare
2:67:3358:14:28:306:441:336:12:g_d0_f1:12:g_d0_f1:?:JHSU7@PARTNERS.ORG
2:68:3376:28:14:306:406:308:12:g_d0_f1:12:g_d0_f1:?:Thomas G. McGuire
2:69:3393:14:14:306:470:294:12:g_d0_f1:12:g_d0_f1:?:Department of Health Care Policy
2:70:3425:14:14:306:424:280:12:g_d0_f1:12:g_d0_f1:?:Harvard Medical School
2:71:3447:14:14:306:419:266:12:g_d0_f1:12:g_d0_f1:?:180 Longwood Avenue
2:72:3466:14:14:306:398:252:12:g_d0_f1:12:g_d0_f1:?:Boston, MA 02115
2:73:3482:14:14:306:358:238:12:g_d0_f1:12:g_d0_f1:?:and NBER
2:74:3490:14:0:306:457:224:12:g_d0_f1:12:g_d0_f1:?:mcguire@hcp.med.harvard.edu
3:75:3517:0:15:72:527:709:121:g_d0_f2:121:g_d0_f2:B: The health economics literature contains two types of selection models.  One holds insurance 
3:76:3611:15:16:71:518:694:121:g_d0_f3:121:g_d0_f2:B:contracts fixed and makes the weak assumption that the demand for contracts with more generous 
3:77:3706:16:15:71:530:678:121:g_d0_f3:121:g_d0_f2:B:reimbursement is positively correlated with anticipated health care use.  If premiums are the same for 
3:78:3809:15:16:71:519:663:121:g_d0_f3:121:g_d0_f2:B:every person with given observable characteristics who chooses a given contract, as is generally the 
3:79:3910:16:15:71:537:647:121:g_d0_f3:121:g_d0_f2:B:case, and if consumers have a choice of contracts, the resulting adverse selection implies an equilibrium 
3:80:4016:15:16:71:519:632:121:g_d0_f3:121:g_d0_f2:B:with too few people choosing more generous contracts (Feldman and Dowd 1982; Cutler and Reber 
3:81:4110:16:15:71:540:616:121:g_d0_f3:121:g_d0_f2:B:1998; Einav, et al. 2010; Einav and Finkelstein 2011).  In the extreme, a death spiral can ensue, and more 
3:82:4217:15:15:71:519:601:121:g_d0_f3:121:g_d0_f2:B:generous plans can disappear altogether (Shore and Bertko 1999; Yegian, et al. 2000; Weinberg and 
3:83:4315:15:26:71:142:586:121:g_d0_f3:121:g_d0_f2:B:Kramer 2011).   
3:84:4331:26:15:107:518:560:121:g_d0_f3:121:g_d0_f2:A:A second model focuses on the incentives of insurers to attract better than average risks by 
3:85:4424:15:16:71:514:545:121:g_d0_f3:121:g_d0_f2:B:tailoring insurance options to attract them (Rothschild and Stiglitz 1976; Newhouse 1996; Hendren 
3:86:4522:16:15:71:535:529:121:g_d0_f3:121:g_d0_f2:B:2012).  Inefficiency takes the form of insurance contracts with the wrong mix of premiums and benefits 
3:87:4625:15:16:71:520:514:121:g_d0_f3:121:g_d0_f2:B:and/or of resources devoted to particular benefit areas (Frank, et al. 2000).  As is well known, in this 
3:88:4730:16:15:71:535:498:121:g_d0_f3:121:g_d0_f2:B:type of model an equilibrium may or may not exist depending on assumptions about the distribution of 
3:89:4831:15:26:71:494:483:121:g_d0_f3:121:g_d0_f2:B:risks and insurers’ behavior (Wilson 1977; Dubey and Geanakoplos 2002; Breyer, et al. 2012).   
3:90:4926:26:15:71:531:457:121:g_d0_f2:121:g_d0_f2:B: A prominent empirical example of selection in the health economics literature has been Part C 
3:91:5021:15:15:71:535:442:121:g_d0_f3:121:g_d0_f2:B:of Medicare, or Medicare Advantage (MA).  Until 2006 insurers participating in the MA program agreed 
3:92:5122:15:16:71:531:427:121:g_d0_f3:121:g_d0_f2:B:to accept a fixed sum per enrollee to provide benefits at least as comprehensive as the “public option” 
3:93:5226:16:15:71:511:411:121:g_d0_f3:121:g_d0_f2:B:of Traditional Medicare (TM).1  This take‐it‐or‐leave‐it fixed sum was a function of spending by the 
3:94:5327:15:16:71:542:396:121:g_d0_f3:121:g_d0_f2:B:average TM beneficiary in the MA plan’s county, although the nature of the function changed over time.  
3:95:5431:16:15:71:540:380:121:g_d0_f3:121:g_d0_f2:B:Starting in 2006 and continuing to the present, each insurer submits a bid rather than simply agreeing to 
3:96:5537:15:16:72:526:365:121:g_d0_f3:121:g_d0_f2:B:a take‐it‐or‐leave‐it price set by Medicare.  But a modified version of the pre‐2006 administered price 
3:97:5641:16:15:71:527:349:121:g_d0_f3:121:g_d0_f2:B:system lives on; instead of the insurer’s receiving a fixed price; the beneficiary receives an analog to a 
3:98:5748:15:16:71:534:334:121:g_d0_f3:121:g_d0_f2:B:voucher that equals the average fixed amount that would have been paid to the insurer if the pre‐2006 
3:99:5850:16:15:71:540:318:121:g_d0_f3:121:g_d0_f2:B:program had continued.  If the insurer’s bid is less than the amount of the “voucher,” and almost all bids 
3:100:5957:15:15:71:524:303:121:g_d0_f3:121:g_d0_f2:B:are, the beneficiary receives 50‐70% of the difference between the bid and the voucher as additional 
3:101:6058:15:16:71:540:288:121:g_d0_f3:121:g_d0_f2:B:services or lower out‐of‐pocket payments.  The government keeps the other 30‐50%.  In the few cases in 
3:102:6161:16:15:71:527:272:121:g_d0_f3:121:g_d0_f2:B:which the bid exceeds the voucher, the beneficiary pays the entire increment.  Importantly, TM is not 
3:103:6263:15:26:71:431:257:121:g_d0_f3:121:g_d0_f2:B:part of this bidding system.  For more detail see (Newhouse and McGuire 2014). 
3:104:6342:26:15:107:522:231:121:g_d0_f3:121:g_d0_f2:A:An MA insurer competes with both TM and with other MA insurers through the terms of the 
3:105:6430:15:16:71:532:216:121:g_d0_f3:121:g_d0_f2:B:contracts or insurance plans that they offer beneficiaries.  At a high level of generality the attraction of 
3:106:6539:16:15:71:509:200:121:g_d0_f3:121:g_d0_f2:B:MA relative to TM for a beneficiary without supplementary insurance (Medigap) is much less cost 
3:107:6635:15:25:71:536:185:121:g_d0_f3:121:g_d0_f2:B:sharing at the point of service and often additional covered services such as vision or dental.2  In return, 
3:108:6744:25:8:71:218:160:121:g_d0_f2:121:g_d0_f2:B:                                                            
3:109:6804:8:17:72:518:152:42:g_d0_f3:100:g_d0_f2:F:1 The requirement that benefits be at least as comprehensive as TM meant (and means) that MA plans had to 
3:110:6910:17:12:71:534:135:100:g_d0_f3:100:g_d0_f2:F:cover any service covered by TM, for example, physician visits.  Further, the actuarial value of any beneficiary out‐
3:111:7027:12:12:71:535:123:100:g_d0_f3:100:g_d0_f2:F:of‐pocket payments in the MA plan, both premiums and cost sharing, could not (and cannot) exceed the actuarial 
3:112:7138:12:12:71:535:111:100:g_d0_f3:100:g_d0_f2:F:value of the cost sharing in TM.  MA participants were (and are) required to be enrolled in Part B and pay the Part 
3:113:7254:12:8:71:121:99:100:g_d0_f3:100:g_d0_f2:F:B premium. 
3:114:7265:8:17:72:534:91:42:g_d0_f3:100:g_d0_f2:F:2 A beneficiary enrolling in TM has the option of purchasing an individual Medigap plan to cover most or all of the 
3:115:7381:17:0:71:533:74:100:g_d0_f3:100:g_d0_f2:F:cost sharing in TM, in effect converting the additional cost sharing in TM relative to MA to an additional premium 
4:116:7496:0:15:72:534:709:121:g_d0_f3:121:g_d0_f2:B:the beneficiary agrees to change the terms at which he or she can use certain physicians or hospitals; if 
4:117:7602:15:16:71:536:694:121:g_d0_f3:121:g_d0_f2:B:a given physician or hospital is not in the MA plan’s network, the beneficiary’s out‐of‐pocket cost to use 
4:118:7709:16:25:71:524:678:121:g_d0_f3:121:g_d0_f2:B:that physician or hospital would likely be considerably above what the beneficiary would pay in TM.   
4:119:7811:25:16:107:531:653:121:g_d0_f3:121:g_d0_f2:A:Each MA insurer has an incentive to design their plan to attract participants whose spending is 
4:120:7907:16:15:71:524:637:121:g_d0_f3:121:g_d0_f2:B:below the MA plan’s bid, net of the risk adjustment payments we describe below.  Except for the risk 
4:121:8008:15:16:71:537:622:121:g_d0_f3:121:g_d0_f2:B:adjustment payments, this incentive is the same as that of insurers in the well‐known Rothschild‐Stiglitz 
4:122:8114:16:15:72:537:606:121:g_d0_f3:121:g_d0_f2:B:(1976) model, the second type of selection model referred to above.  Plans must accept all beneficiaries 
4:123:8219:15:15:71:540:591:121:g_d0_f3:121:g_d0_f2:B:who want to join, so to affect the distribution of costs among enrollees, plans must influence who wants 
4:124:8324:15:16:71:510:576:121:g_d0_f3:121:g_d0_f2:B:to join them in the first place.  Their main instruments for doing so are their choice of networks of 
4:125:8426:16:15:71:534:560:121:g_d0_f3:121:g_d0_f2:B:providers and structure of drug formularies, as well as their marketing and choice of geographic area in 
4:126:8531:15:26:71:350:545:121:g_d0_f3:121:g_d0_f2:B:which to operate (Frank et al. 2000; Cao and McGuire 2003).   
4:127:8593:26:15:71:507:519:121:g_d0_f2:121:g_d0_f2:B: In the Rothschild‐Stiglitz model there is no regulator of the contracts that can be offered, 
4:128:8687:15:16:71:537:504:121:g_d0_f3:121:g_d0_f2:B:whereas the Medicare Advantage program uses a number of instruments to mitigate selection behavior 
4:129:8786:16:15:71:525:488:121:g_d0_f3:121:g_d0_f2:B:by plans, as we describe below.3  A key issue is how effective these instruments are.  Historically they 
4:130:8891:15:16:71:524:473:121:g_d0_f3:121:g_d0_f2:B:were not very effective, so Medicare has introduced additional anti‐selection instruments in the past 
4:131:8993:16:25:71:115:457:121:g_d0_f3:121:g_d0_f2:B:decade.   
4:132:9003:25:15:107:537:432:121:g_d0_f3:121:g_d0_f2:A:Two groups of economists have studied the effect of the introduction of these new instruments 
4:133:9097:15:16:71:504:417:121:g_d0_f3:121:g_d0_f2:B:and reached different conclusions.  Our group has published three papers that suggest favorable 
4:134:9193:16:15:71:530:401:121:g_d0_f3:121:g_d0_f2:B:selection in MA has fallen markedly, but that some remains (McWilliams, et al. 2012; Newhouse, et al. 
4:135:9295:15:16:71:532:386:121:g_d0_f3:121:g_d0_f2:B:2012; Newhouse, et al. 2013).  By contrast, Brown, et al. have concluded that plans found new ways to 
4:136:9397:16:15:71:539:370:121:g_d0_f3:121:g_d0_f2:B:select in response to Medicare regulations so as to increase the degree of favorable selection (Brown, et 
4:137:9503:15:16:71:506:355:121:g_d0_f3:121:g_d0_f2:B:al. 2011).  In the remainder of this paper we briefly review the evidence to date and present new 
4:138:9601:16:15:71:532:339:121:g_d0_f3:121:g_d0_f2:B:evidence by re‐estimating an approximation to Brown, et al.’s key equation on a much larger data set.  
4:139:9704:15:16:71:520:324:121:g_d0_f3:121:g_d0_f2:B:The effectiveness of the new instruments is an important issue for the Medicare program, as well as 
4:140:9804:16:25:71:446:308:121:g_d0_f3:121:g_d0_f2:B:other publicly regulated programs, including the ACA’s health insurance exchanges. 
4:141:9887:25:15:107:525:283:121:g_d0_f3:121:g_d0_f2:A:We conclude that selection has fallen markedly among the main group of persons enrolled in 
4:142:9978:15:16:71:528:268:121:g_d0_f3:121:g_d0_f2:B:the MA Coordinated Care Program (primarily HMOs but also PPO’s), the elderly who are not Medicaid 
4:143:10076:16:15:71:523:252:121:g_d0_f3:121:g_d0_f2:B:eligible (“non‐duals”), who are not institutionalized, and whose initial basis of eligibility was old age.  
4:144:10184:15:16:71:528:237:121:g_d0_f3:121:g_d0_f2:B:Nonetheless, some modest selection remains.    Ascertaining whether selection changed among other 
4:145:10282:16:15:71:521:221:121:g_d0_f3:121:g_d0_f2:B:groups of persons enrolled in MA is difficult because of small numbers and legislative changes in the 
4:146:10384:15:22:71:519:206:121:g_d0_f3:121:g_d0_f2:B:design of the plans available to them.4  Whereas the second model of selection that focuses on plan 
4:147:10484:22:12:71:541:184:121:g_d0_f2:121:g_d0_f2:B:                                                                                                                                                                                                
4:148:10676:12:12:72:540:172:100:g_d0_f3:100:g_d0_f2:F:relative to MA.  Around 30 percent of beneficiaries have a supplementary plan that is partly or fully subsidized by a 
4:149:10794:12:13:71:511:160:100:g_d0_f3:100:g_d0_f2:F:prior employer, although this may be structured as a lump sum subsidy with Medicare Advantage plans as a 
4:150:10899:13:12:71:539:147:100:g_d0_f3:100:g_d0_f2:F:choice.  Poorer Medicare beneficiaries are eligible for Medicaid, which historically functioned like a supplementary 
4:151:11016:12:12:72:540:135:100:g_d0_f3:100:g_d0_f2:F:plan to TM, although many states are currently enrolling Medicaid beneficiaries in MA with the ability to opt out to 
4:152:11133:12:7:71:89:123:100:g_d0_f3:100:g_d0_f2:F:TM. 
4:153:11137:7:12:72:516:116:42:g_d0_f3:100:g_d0_f2:F:3 Employers play this role in the commercial market by choice of plans to offer employees and subsidy policy. 
4:154:11247:12:18:72:516:104:42:g_d0_f3:100:g_d0_f2:F:4 The other groups include those whose original reason for eligibility was not old age (about 16% of Medicare 
4:155:11357:18:12:71:534:86:100:g_d0_f3:100:g_d0_f2:F:beneficiaries are disabled under 65 in 2009), those also eligible for Medicaid (18% of Medicare beneficiaries), and 
4:156:11473:12:0:71:511:74:100:g_d0_f3:100:g_d0_f2:F:those institutionalized (about 5% of the Medicare population).  These groups are not mutually exclusive; for 
5:157:11582:0:15:72:516:709:121:g_d0_f3:121:g_d0_f2:B:incentives implies that in principle better regulation might ameliorate the selection, the first model 
5:158:11685:15:16:71:521:694:121:g_d0_f3:121:g_d0_f2:B:implies there may be some inherent characteristics of TM and the current structure of the Medicare 
5:159:11784:16:25:71:417:678:121:g_d0_f3:121:g_d0_f2:B:program that lead to at least some residual selection between MA and TM.    
5:160:11860:25:26:71:299:653:121:g_d0_f4:121:g_d0_f5:C:Background on the Medicare Advantage Program 
5:161:11905:26:15:107:537:627:121:g_d0_f3:121:g_d0_f2:A:MA plans face two problems in competing against TM.  First, the unit prices they negotiate with 
5:162:12001:15:16:71:538:612:121:g_d0_f3:121:g_d0_f2:B:physicians and hospitals are typically above the take‐it‐or‐leave‐it prices paid by TM.  Second, they must 
5:163:12108:16:15:71:533:596:121:g_d0_f3:121:g_d0_f2:B:finance the lower cost sharing they offer. To compete therefore, MA plans must reduce the quantity of 
5:164:12210:15:15:72:511:581:121:g_d0_f3:121:g_d0_f2:B:services they pay for, either through medical management of chronic diseases (e.g., attempting to 
5:165:12308:15:16:71:537:566:121:g_d0_f3:121:g_d0_f2:B:increase compliance with prescribed medication and thereby lowering the likelihood of hospitalization), 
5:166:12412:16:15:71:509:550:121:g_d0_f3:121:g_d0_f2:B:choosing physicians to be in their network who practice conservatively, or with the mechanism of 
5:167:12509:15:16:71:534:535:121:g_d0_f3:121:g_d0_f2:B:interest to us, offering networks of providers and drug formularies and configuring cost sharing in ways 
5:168:12614:16:25:71:487:519:121:g_d0_f3:121:g_d0_f2:B:that will attract good risks, as envisioned in the second model of selection described above.   
5:169:12710:25:16:107:530:494:121:g_d0_f3:121:g_d0_f2:A:The first type of selection model, however, could also be relevant.  Not surprisingly those with 
5:170:12807:16:15:71:529:478:121:g_d0_f3:121:g_d0_f2:B:multiple illnesses on average use more providers than those with no or a single health problem, as we 
5:171:12909:15:16:71:517:463:121:g_d0_f3:121:g_d0_f2:B:show below.  These persons, who also may have more complex disease or at least greater concerns 
5:172:13005:16:15:71:526:447:121:g_d0_f3:121:g_d0_f2:B:about complexity associated with having multiple comorbid conditions, could prefer TM’s freedom of 
5:173:13104:15:15:71:517:432:121:g_d0_f3:121:g_d0_f2:B:choice of provider (almost all providers participate in TM), since the more providers the beneficiary 
5:174:13206:15:16:71:528:417:121:g_d0_f3:121:g_d0_f2:B:uses, the greater the chance that one or more of them is not in an MA plan’s network.   Networks and 
5:175:13307:16:15:71:541:401:121:g_d0_f3:121:g_d0_f2:B:formularies are inherent in MA, since MA plans must have a credible threat to exclude the provider from 
5:176:13411:15:16:71:539:386:121:g_d0_f3:121:g_d0_f2:B:their network to negotiate price.5  If selection of this type is going on, beneficiaries in MA plans will tend 
5:177:13522:16:15:71:517:370:121:g_d0_f3:121:g_d0_f2:B:to be “healthier” and less costly than those in TM, but better regulation cannot address it given the 
5:178:13624:15:26:71:276:355:121:g_d0_f3:121:g_d0_f2:B:current structure of the Medicare program.6   
5:179:13670:26:15:108:515:329:121:g_d0_f3:121:g_d0_f2:A:Medicare employs several instruments to mitigate plans’ selection incentives.  First, it “risk 
5:180:13765:15:16:71:502:314:121:g_d0_f3:121:g_d0_f2:B:adjusts” the amounts it pays MA plans.  The general idea is that Medicare makes budget neutral 
5:181:13860:16:15:71:534:298:121:g_d0_f3:121:g_d0_f2:B:transfers among MA plans according to certain observed characteristics of each plan’s mix of enrollees; 
5:182:13964:15:15:71:541:283:121:g_d0_f3:121:g_d0_f2:B:thus, plans whose enrollees are below average in expected cost are paid less than those whose enrollees 
5:183:14068:15:16:71:540:268:121:g_d0_f3:121:g_d0_f2:B:are above average in expected cost.  TM, however, is not part of this transfer system.  Up until 2000, the 
5:184:14175:16:15:71:535:252:121:g_d0_f3:121:g_d0_f2:B:algorithm to determine a beneficiary’s expected cost accounted for only demographic variables such as 
5:185:14277:15:16:71:521:237:121:g_d0_f3:121:g_d0_f2:B:age, gender, Medicaid eligibility, whether the beneficiary was institutionalized, and the beneficiary’s 
5:186:14381:16:24:71:508:221:121:g_d0_f3:121:g_d0_f2:B:county of residence.  These variables were used to predict spending by TM beneficiaries and thus 
5:187:14478:24:13:71:541:197:121:g_d0_f2:121:g_d0_f2:B:                                                                                                                                                                                                
5:188:14670:13:12:72:518:184:100:g_d0_f3:100:g_d0_f2:F:example, 44% of the dual eligible group was under 65.  Percentages are from the Medicare Payment Advisory 
5:189:14776:12:12:71:530:172:100:g_d0_f3:100:g_d0_f2:F:Commission 2013 Data Book (Medicare Payment Advisory Commission 2013).  As we describe below, in the time 
5:190:14882:12:8:71:409:160:100:g_d0_f3:100:g_d0_f2:F:period we examine, these groups were underrepresented in Medicare Advantage.  
5:191:14960:8:17:72:524:152:42:g_d0_f3:100:g_d0_f2:F:5 Starting in 2012 the MA program has paid bonuses to plans based on the observed quality of care.  Plans thus 
5:192:15071:17:12:71:521:135:100:g_d0_f3:100:g_d0_f2:F:have an incentive to exclude from their network or charge high copayments to see providers whose measured 
5:193:15177:12:7:71:129:123:100:g_d0_f3:100:g_d0_f2:F:quality is low. 
5:194:15193:7:17:72:525:116:42:g_d0_f3:100:g_d0_f2:F:6 In principle, such selection could be addressed with sufficiently good risk adjustment in a voucher like scheme 
5:195:15307:17:13:71:534:99:100:g_d0_f3:100:g_d0_f2:F:that included TM, for example, the premium support proposal of Senator Wyden and Representative Ryan (Antos 
5:196:15415:13:12:71:519:86:100:g_d0_f3:100:g_d0_f2:F:2012).  Nonetheless, there would not be efficient sorting of beneficiaries between TM and MA for reasons we 
5:197:15523:12:0:72:182:74:100:g_d0_f3:100:g_d0_f2:F:describe in the conclusion. 
6:198:15551:0:15:72:535:709:121:g_d0_f3:121:g_d0_f2:B:yielded relative supply prices for individuals in MA plans with given characteristics.  For example, a plan 
6:199:15659:15:16:71:536:694:121:g_d0_f3:121:g_d0_f2:B:that hypothetically enrolled only 65‐69 year old males in a given county would have been paid less than 
6:200:15763:16:15:71:524:678:121:g_d0_f3:121:g_d0_f2:B:a plan that hypothetically enrolled only 70‐74 years old males in the same county.  Second, Medicare 
6:201:15864:15:16:71:519:663:121:g_d0_f3:121:g_d0_f2:B:regulates network and formulary adequacy; a plan’s network, for example, must include a sufficient 
6:202:15963:16:15:71:502:647:121:g_d0_f3:121:g_d0_f2:B:number of oncologists.  Third, Medicare regulates a plan’s choice of geographic area in which to 
6:203:16060:15:16:71:540:632:121:g_d0_f3:121:g_d0_f2:B:operate; generally a plan must either operate in an entire county or not enter the market in that county; 
6:204:16166:16:15:71:531:616:121:g_d0_f3:121:g_d0_f2:B:it requires special approval to choose particular zip codes within a county in which to operate.  Fourth, 
6:205:16272:15:15:71:527:601:121:g_d0_f3:121:g_d0_f2:B:as mentioned above, Medicare constrains the amount of cost sharing; the actuarial value of a plan, or 
6:206:16374:15:16:71:528:586:121:g_d0_f3:121:g_d0_f2:B:the percentage of an average beneficiary’s cost that the contract covers, must equal or exceed that of 
6:207:16477:16:15:71:536:570:121:g_d0_f3:121:g_d0_f2:B:TM.  Thus, a plan’s ability to attract good risks by offering even higher cost sharing and lower premiums 
6:208:16583:15:16:71:532:555:121:g_d0_f3:121:g_d0_f2:B:than TM, a standard kind of selection tool in unregulated insurance markets, is limited.  In practice this 
6:209:16690:16:15:71:514:539:121:g_d0_f3:121:g_d0_f2:B:actuarial value constraint is rarely binding, because, as noted above, MA plans typically offer much 
6:210:16791:15:16:71:535:524:121:g_d0_f3:121:g_d0_f2:B:lower cost sharing than TM.  Finally, Medicare has an overarching authority to refuse to contract with a 
6:211:16896:16:25:71:264:508:121:g_d0_f3:121:g_d0_f2:B:plan that it deems as engaged in selection. 
6:212:16940:25:16:107:522:483:121:g_d0_f3:121:g_d0_f2:A:The health economics literature, however, has convincingly demonstrated that in the 1990’s 
6:213:17031:16:15:71:534:467:121:g_d0_f3:121:g_d0_f2:B:these various anti‐selection tools did not prevent favorable selection into MA plans.  The Congressional 
6:214:17136:15:15:71:536:452:121:g_d0_f3:121:g_d0_f2:B:Budget Office estimated that in the mid 1990’s Medicare on average paid 8% more for the beneficiaries 
6:215:17238:15:16:71:537:437:121:g_d0_f3:121:g_d0_f2:B:in MA than if those same beneficiaries had enrolled in TM ‐ despite Medicare’s paying a take‐it‐or‐leave‐
6:216:17343:16:15:71:537:421:121:g_d0_f3:121:g_d0_f2:B:it price that at that time was 95% of the average TM spending in a county for a beneficiary with average 
6:217:17448:15:16:71:525:406:121:g_d0_f3:121:g_d0_f2:B:risk (Congressional Budget Office 1997; Morgan, et al. 1997; Cutler and Zeckhauser 2000; Glied 2000; 
6:218:17549:16:25:71:339:390:121:g_d0_f3:121:g_d0_f2:B:Newhouse 2002; McGuire, et al. 2011; Breyer et al. 2012).   
6:219:17609:25:16:71:529:365:121:g_d0_f2:121:g_d0_f2:B: As a result of the observed favorable selection into MA, Medicare took two additional steps in 
6:220:17705:16:15:71:497:349:121:g_d0_f3:121:g_d0_f2:B:the past decade to decrease selection.  First, it incorporated diagnostic information into its risk 
6:221:17805:15:16:71:521:334:121:g_d0_f3:121:g_d0_f2:B:adjustment scheme.  Specifically, starting in 2000 Medicare adjusted its then fixed payment to plans 
6:222:17906:16:15:71:529:318:121:g_d0_f3:121:g_d0_f2:B:using information on inpatient diagnoses, but gave that system only 10% weight; the other 90% of the 
6:223:18007:15:15:71:510:303:121:g_d0_f3:121:g_d0_f2:B:weight continued to be on the old demographic system.7  This system continued until 2004, when 
6:224:18102:15:16:71:529:288:121:g_d0_f3:121:g_d0_f2:B:Medicare began a transition to a system that incorporated diagnostic information from both inpatient 
6:225:18203:16:15:71:517:272:121:g_d0_f3:121:g_d0_f2:B:and outpatient settings (Pope, et al. 2004).  That system, which Medicare continues to use, is called 
6:226:18305:15:16:71:539:257:121:g_d0_f3:121:g_d0_f2:B:CMS‐HCC’s or just HCC’s, and in 2004 it had 30% weight in determining payment, in 2005 50% weight, in 
6:227:18407:16:15:71:496:241:121:g_d0_f3:121:g_d0_f2:B:2006 75% weight, and the transition was complete in 2007.  Which enrollees are profitable are 
6:228:18501:15:16:71:534:226:121:g_d0_f3:121:g_d0_f2:B:influenced by these weights, which we exploit later in our year‐by‐year analyses.  During the transition, 
6:229:18607:16:25:71:521:210:121:g_d0_f3:121:g_d0_f2:B:the remaining weight was on the old system that consisted mostly (90%) of demographic variables.   
6:230:18706:25:16:71:529:185:121:g_d0_f2:121:g_d0_f2:B: The HCC risk adjustment system effectively sets a relative price for each plan enrollee that is a 
6:231:18805:16:15:71:532:169:121:g_d0_f3:121:g_d0_f2:B:function of the relative spending to treat an enrollee with similar observable characteristics in TM.  For 
6:232:18912:15:15:71:517:154:121:g_d0_f3:121:g_d0_f2:B:example, an MA plan would be reimbursed considerably more for a 75 year old woman living in the 
6:233:19008:15:40:71:509:139:121:g_d0_f3:121:g_d0_f2:B:community with congestive heart failure (HCC80) than for a 75 year old woman living in the same 
6:234:19104:40:8:71:218:99:121:g_d0_f2:121:g_d0_f2:B:                                                            
6:235:19164:8:17:72:512:91:42:g_d0_f3:100:g_d0_f2:F:7 The small weight on the diagnosis‐based system was to mitigate an incentive to hospitalize just to record a 
6:236:19274:17:0:71:114:74:100:g_d0_f3:100:g_d0_f2:F:diagnosis. 
7:237:19285:0:15:72:520:709:121:g_d0_f3:121:g_d0_f2:B:community with breast cancer (HCC10) (Pope et al. 2004).  Like the old system, however, this newer 
7:238:19384:15:26:71:472:694:121:g_d0_f3:121:g_d0_f2:B:system just makes budget neutral transfers among MA plans; it does not incorporate TM. 
7:239:19471:26:15:71:530:668:121:g_d0_f2:121:g_d0_f2:B: Second, Medicare made it more difficult for beneficiaries to move between TM and MA.  Prior 
7:240:19564:15:16:71:511:653:121:g_d0_f3:121:g_d0_f2:B:to 2006 Medicare allowed a beneficiary to move between MA and TM at the end of any month, in 
7:241:19657:16:15:71:532:637:121:g_d0_f3:121:g_d0_f2:B:contrast to commercial insurance where an individual typically chooses a health insurance contract for 
7:242:19760:15:16:71:509:622:121:g_d0_f3:121:g_d0_f2:B:an entire year during an annual open enrollment period.  The ability for Medicare beneficiaries to 
7:243:19859:16:15:71:537:606:121:g_d0_f3:121:g_d0_f2:B:change from MA to TM monthly was initially seen as a beneficiary protection against underservice by or 
7:244:19962:15:15:71:498:591:121:g_d0_f3:121:g_d0_f2:B:dissatisfaction with an MA plan but it facilitated selection, since a beneficiary in MA with a new 
7:245:20061:15:16:71:510:576:121:g_d0_f3:121:g_d0_f2:B:diagnosis who wanted to use an out‐of‐network physician to treat the problem could move to TM 
7:246:20155:16:25:71:170:560:121:g_d0_f3:121:g_d0_f2:B:almost immediately.   
7:247:20177:25:16:107:537:535:121:g_d0_f3:121:g_d0_f2:A:Starting in 2006, however, a beneficiary who chose MA was locked in to the chosen plan for the 
7:248:20272:16:15:71:544:519:121:g_d0_f3:121:g_d0_f2:B:last six months of the calendar year, but could still change plans monthly during the first half of the year.  
7:249:20383:15:16:71:533:504:121:g_d0_f3:121:g_d0_f2:B:Beginning in 2007 the lock‐in period was the last 9 months and in 2011 it was extended to the last 10.5 
7:250:20487:16:15:71:531:488:121:g_d0_f3:121:g_d0_f2:B:months of the year.  Nonetheless, by allowing a plan change in the first six weeks of the year Medicare 
7:251:20591:15:16:71:501:473:121:g_d0_f3:121:g_d0_f2:B:remains less restrictive than commercial insurance.  The lock‐in, however, does not apply to the 
7:252:20688:16:25:71:450:457:121:g_d0_f3:121:g_d0_f2:B:minority of Medicare beneficiaries also eligible for Medicaid, so‐called dual eligibles. 
7:253:20777:25:15:107:516:432:121:g_d0_f3:121:g_d0_f2:A:Coincident with these changes, Medicare also introduced new types of MA plans that were 
7:254:20865:15:16:71:537:417:121:g_d0_f3:121:g_d0_f2:B:limited to certain beneficiaries.  In particular, two types of Special Needs Plans (SNP’s) were introduced, 
7:255:20973:16:15:71:532:401:121:g_d0_f3:121:g_d0_f2:B:one for dual eligibles (those also eligible for Medicaid) and one for the institutionalized.8  Another type 
7:256:21081:15:16:71:517:386:121:g_d0_f3:121:g_d0_f2:B:of plan, private fee‐for‐service plans, were authorized in 1997 legislation and entered the market in 
7:257:21183:16:15:71:523:370:121:g_d0_f3:121:g_d0_f2:B:1998.  They were open to all beneficiaries, but attracted few enrollees before 2004, after which time 
7:258:21285:15:16:71:531:355:121:g_d0_f3:121:g_d0_f2:B:they grew rapidly. These plans, however, had very different characteristics than the other MA options, 
7:259:21388:16:25:72:259:339:121:g_d0_f3:121:g_d0_f2:B:which we describe in more detail below.   
7:260:21430:25:26:71:207:314:121:g_d0_f4:121:g_d0_f2:B:Estimates of Selection Effects 
7:261:21461:26:15:107:496:288:121:g_d0_f3:121:g_d0_f2:A:Virtually all the historical evidence on selection and much of the more recent evidence 
7:262:21549:15:15:71:522:273:121:g_d0_f3:121:g_d0_f2:B:compares use of medical services among those currently in TM who subsequently switch to MA with 
7:263:21645:15:16:71:532:258:121:g_d0_f3:121:g_d0_f2:B:those who remain in TM.  The limitation to those in TM reflects the availability of TM data and the lack 
7:264:21750:16:15:71:539:242:121:g_d0_f3:121:g_d0_f2:B:of analogous MA data.  In addition to examining those in TM who switch to MA, the literature also often 
7:265:21854:15:16:71:487:227:121:g_d0_f3:121:g_d0_f2:B:compares those now in TM who recently left MA with those who were always in TM.9  These 
7:266:21942:16:15:72:524:211:121:g_d0_f3:121:g_d0_f2:B:comparisons are typically adjusted for age, gender, Medicaid status, employment status, and county, 
7:267:22042:15:26:71:395:196:121:g_d0_f3:121:g_d0_f2:B:which were also the principal adjusters for plan payment in the 1990’s.   
7:268:22116:26:15:107:526:170:121:g_d0_f3:121:g_d0_f2:A:The early literature cited above, using data from the 1990’s, found that those enrolling in MA 
7:269:22211:15:19:71:541:155:121:g_d0_f3:121:g_d0_f2:B:were relatively low utilizers when they were enrolled in TM immediately prior to their enrollment in MA, 
7:270:22316:19:8:71:218:136:121:g_d0_f2:121:g_d0_f2:B:                                                            
7:271:22376:8:17:72:538:128:42:g_d0_f3:100:g_d0_f2:F:8 There were also separate plans for those with certain chronic diseases.  Of the various types of SNP’s, the one for 
7:272:22494:17:12:71:499:111:100:g_d0_f3:100:g_d0_f2:F:the duals dominated numerically; 83% of SNP enrollees were in those plans (Medicare Payment Advisory 
7:273:22595:12:8:71:151:99:100:g_d0_f3:100:g_d0_f2:F:Commission 2007). 
7:274:22613:8:17:72:503:91:42:g_d0_f3:100:g_d0_f2:F:9 Selection, of course, is unidentified if one simply compares use in TM and MA contemporaneously, since 
7:275:22718:17:0:71:513:74:100:g_d0_f3:100:g_d0_f2:F:differences could arise from selection, differences in medical management, and differences in cost sharing.   
8:276:22828:0:15:72:541:709:121:g_d0_f3:121:g_d0_f2:B:when compared with those who remained in TM and did not switch to MA.  Data on the use of the much 
8:277:22927:15:16:71:531:694:121:g_d0_f3:121:g_d0_f2:B:less numerous group disenrolling from MA were mildly conflicting; some data showed the disenrollees 
8:278:23027:16:15:71:537:678:121:g_d0_f3:121:g_d0_f2:B:to be relatively high users after moving to TM when compared with the group that had remained in TM, 
8:279:23128:15:16:72:535:663:121:g_d0_f3:121:g_d0_f2:B:and other data showed the use of the two groups was similar.  In short, these data suggested that good 
8:280:23231:16:15:71:528:647:121:g_d0_f3:121:g_d0_f2:B:risks were enrolling in MA and bad risks might be disenrolling (Physician Payment Review Commission 
8:281:23331:15:16:71:538:632:121:g_d0_f3:121:g_d0_f2:B:1996; Medicare Payment Advisory Commission 2000).  It was on the basis of such comparisons between 
8:282:23430:16:25:72:522:616:121:g_d0_f3:121:g_d0_f2:B:switchers and stayers that the CBO determined that MA program added to Medicare program cost.   
8:283:23526:25:15:107:524:591:121:g_d0_f3:121:g_d0_f2:A:There are three problems with inferring selection from such studies.  The first two arise from 
8:284:23621:15:16:71:541:576:121:g_d0_f3:121:g_d0_f2:B:status quo bias, the tendency of beneficiaries to remain in the same plan year after year (Samuelson and 
8:285:23726:16:15:71:540:560:121:g_d0_f3:121:g_d0_f2:B:Zeckhauser 1988).  First, because of status quo bias, only a small percentage of beneficiaries switch from 
8:286:23833:15:16:71:526:545:121:g_d0_f3:121:g_d0_f2:B:TM to MA each year, as we confirm below.  As a result, even if those who switch exhibit the expected 
8:287:23934:16:15:71:534:529:121:g_d0_f3:121:g_d0_f2:B:type of selection, the characteristics of the much larger stock of beneficiaries who remain in their plans 
8:288:24041:15:26:71:461:514:121:g_d0_f3:121:g_d0_f2:B:year after year could differ substantially from the characteristics of those who switch.   
8:289:24132:26:15:107:524:488:121:g_d0_f3:121:g_d0_f2:A:Second, even if those few who switch differ in their unobserved characteristics at the time of 
8:290:24227:15:16:71:540:473:121:g_d0_f3:121:g_d0_f2:B:the switch, initial differences appear to regress to the mean.  For example, in 1998 the age‐sex‐Medicaid 
8:291:24333:16:15:71:530:457:121:g_d0_f3:121:g_d0_f2:B:adjusted mortality rate among those who were enrolled in MA for less than a year was 21 percent less 
8:292:24434:15:15:71:528:442:121:g_d0_f3:121:g_d0_f2:B:than those who remained in TM, but for those who had been in MA five years or more, the difference 
8:293:24533:15:16:71:537:427:121:g_d0_f3:121:g_d0_f2:B:was only 11 percent (Newhouse, et al., 2012).  We note in passing that these mortality data support the 
8:294:24637:16:15:71:536:411:121:g_d0_f3:121:g_d0_f2:B:inference that in the 1990’s there was favorable selection into MA since it is implausible that any causal 
8:295:24744:15:16:71:519:396:121:g_d0_f3:121:g_d0_f2:B:effect of MA on mortality could be 21 percent or even 11 percent.  Note these mortality differences 
8:296:24844:16:25:71:493:380:121:g_d0_f3:121:g_d0_f2:B:apply to the stock of beneficiaries in each type of plan, not just the small flow between them.  
8:297:24941:25:16:107:537:355:121:g_d0_f3:121:g_d0_f2:A:The third problem is methodological.  One would like to know the magnitude of selection net of 
8:298:25036:16:15:71:543:339:121:g_d0_f3:121:g_d0_f2:B:those who switch into and out of MA, but a methodological problem interferes with such a calculation.10  
8:299:25141:15:16:72:538:324:121:g_d0_f3:121:g_d0_f2:B:In the period we are examining, however, many fewer persons, only about a fifth as many, switch out of 
8:300:25244:16:15:71:537:308:121:g_d0_f3:121:g_d0_f2:B:MA into TM as switch into MA from TM; hence we focus here on those switching into rather than out of 
8:301:25345:15:25:71:99:293:121:g_d0_f3:121:g_d0_f2:B:MA.11 
8:302:25351:25:16:108:527:268:121:g_d0_f3:121:g_d0_f2:A:More recent data, however, show less evidence of favorable selection than the data from the 
8:303:25443:16:15:71:532:252:121:g_d0_f3:121:g_d0_f2:B:1990s did.  By 2008 the difference in age‐sex‐Medicaid adjusted mortality among those enrolled in MA 
8:304:25544:15:40:71:537:237:121:g_d0_f3:121:g_d0_f2:B:for less than a year had fallen from its 1998 value of 21 percent to 13 percent and the difference among 
8:305:25649:40:8:71:218:197:121:g_d0_f2:121:g_d0_f2:B:                                                            
8:306:25709:8:17:72:530:189:42:g_d0_f3:100:g_d0_f2:F:10 The difficulty in reaching a summary value for those switching in both directions is that the risk score for those 
8:307:25827:17:12:71:528:172:100:g_d0_f3:100:g_d0_f2:F:switching into MA must be based on lagged diagnoses, since historically diagnostic data were not available from 
8:308:25939:12:13:71:500:160:100:g_d0_f3:100:g_d0_f2:F:MA enrollees.  For the same reason among those disenrolling the risk score must be based on concurrent 
8:309:26042:13:12:71:533:147:100:g_d0_f3:100:g_d0_f2:F:diagnoses because lagged diagnoses are not available; as a result, these scores are not comparable. Nonetheless, 
8:310:26155:12:12:71:488:135:100:g_d0_f3:100:g_d0_f2:F:the difference in numbers of those switching into MA relative to those switching out of MA means the 
8:311:26256:12:12:71:500:123:100:g_d0_f3:100:g_d0_f2:F:characteristics of those switching in, the group we focus on, would likely dominate any summary value of 
8:312:26361:12:7:72:115:111:100:g_d0_f3:100:g_d0_f2:F:selection.  
8:313:26373:7:18:72:533:104:42:g_d0_f3:100:g_d0_f2:F:11 This decision means our conclusions on selection may be somewhat optimistic because those disenrolling from 
8:314:26484:18:12:71:537:86:100:g_d0_f3:100:g_d0_f2:F:MA into TM in the more recent period do appear sicker than those who remain in TM continuously (Newhouse, et 
8:315:26593:12:0:71:119:74:100:g_d0_f3:100:g_d0_f2:F:al., 2012).   
9:316:26607:0:15:72:537:709:121:g_d0_f3:121:g_d0_f2:B:those enrolled five years or more in MA, instead of 11 percent, was an insignificant 1 percent less, again 
9:317:26714:15:26:71:286:694:121:g_d0_f3:121:g_d0_f2:B:consistent with regression toward the mean.12   
9:318:26762:26:15:107:515:668:121:g_d0_f3:121:g_d0_f2:A:Other data in addition to the mortality data suggest selection behavior changed in the past 
9:319:26854:15:16:71:518:653:121:g_d0_f3:121:g_d0_f2:B:decade.  To implement the risk adjustment described above, the Center for Medicare and Medicaid 
9:320:26950:16:15:71:533:637:121:g_d0_f3:121:g_d0_f2:B:Services (CMS) computes a risk score, which is simply the average weight of the HCCs among the plan’s 
9:321:27052:15:16:71:530:622:121:g_d0_f3:121:g_d0_f2:B:enrollees.  The risk score, which is proportional to the average spending in TM for an enrollee with the 
9:322:27157:16:15:71:531:606:121:g_d0_f3:121:g_d0_f2:B:given observable characteristics including diagnosis, changed substantially among those switching into 
9:323:27260:15:15:71:524:591:121:g_d0_f3:121:g_d0_f2:B:MA over the 2004‐2008 period relative to those remaining in TM.  In 2003 those in TM switching into 
9:324:27360:15:16:71:528:576:121:g_d0_f3:121:g_d0_f2:B:MA in 2004 had risk scores that were about 10% less than those who remained in TM, consistent with 
9:325:27459:16:15:71:540:560:121:g_d0_f3:121:g_d0_f2:B:the earlier studies of favorable selection into MA; by 2008 that figure had fallen to 3% (Newhouse, et al., 
9:326:27567:15:26:71:465:545:121:g_d0_f3:121:g_d0_f2:B:2012).13  This period coincided with the introduction of the CMS‐HCC’s and the lock‐in.   
9:327:27657:26:15:107:541:519:121:g_d0_f3:121:g_d0_f2:A:These risk score data, of course, are subject to the caveat noted above that the characteristics of 
9:328:27757:15:16:71:527:504:121:g_d0_f3:121:g_d0_f2:B:the switchers may not closely represent those of the stock of beneficiaries.  McWilliams, et al. (2012), 
9:329:27862:16:15:71:525:488:121:g_d0_f3:121:g_d0_f2:B:however, compared self‐rated health status as well as utilization among the stock of those in MA and 
9:330:27963:15:16:71:498:473:121:g_d0_f3:121:g_d0_f2:B:those in TM over the 2001‐2007 period.  Like the mortality data between 1998 and 2008, these 
9:331:28056:16:15:71:537:457:121:g_d0_f3:121:g_d0_f2:B:comparisons showed a striking change.  The proportion of beneficiaries who rated their health as fair or 
9:332:28161:15:15:71:523:442:121:g_d0_f3:121:g_d0_f2:B:poor, the two worst categories, was over 20% less in MA than in TM in 2001‐2003, but by 2006‐2007 
9:333:28259:15:16:71:512:427:121:g_d0_f3:121:g_d0_f2:B:was only 5% less and one could not reject the null of no significant difference.14  McWilliams, et al. 
9:334:28362:16:15:71:520:411:121:g_d0_f3:121:g_d0_f2:B:(2012) also compared changes in the total utilization of medical services over this period.  If medical 
9:335:28466:15:16:71:513:396:121:g_d0_f3:121:g_d0_f2:B:management techniques were relatively constant, such changes would primarily reflect changes in 
9:336:28562:16:15:71:520:380:121:g_d0_f3:121:g_d0_f2:B:selection.15  Utilization in MA was about 18% less in the 2001‐2003 period, but only about 8% less in 
9:337:28664:15:26:71:510:365:121:g_d0_f3:121:g_d0_f2:B:2006‐2007.  Drug fills, which in 2001‐2003 were less in MA than TM, were greater by 2006‐2007.   
9:338:28761:26:15:107:530:339:121:g_d0_f3:121:g_d0_f2:A:In short, these data suggest that a different mix of beneficiaries began to choose MA, at a rate 
9:339:28858:15:16:71:517:324:121:g_d0_f3:121:g_d0_f2:B:large enough to affect characteristics of the entire stock of beneficiaries in the two plan types.  One 
9:340:28962:16:15:71:531:308:121:g_d0_f3:121:g_d0_f2:B:additional piece of data suggests that by later in the period, the distribution of beneficiaries in MA and 
9:341:29069:15:15:71:535:293:121:g_d0_f3:121:g_d0_f2:B:TM were coming into balance.  Newhouse, et al. (2013) obtained data for 2010‐2011 from one MA plan 
9:342:29168:15:16:71:531:278:121:g_d0_f3:121:g_d0_f2:B:on its revenues and its medical cost (i.e., its payout to physicians, hospitals, etc.) for beneficiaries in 48 
9:343:29279:16:15:71:506:262:121:g_d0_f3:121:g_d0_f2:B:common HCC’s or combinations of HCC’s, e.g., chronic obstructive pulmonary disease, or chronic 
9:344:29374:15:16:71:519:247:121:g_d0_f3:121:g_d0_f2:B:obstructive pulmonary disease and specified heart arrhythmias.  In these data each beneficiary only 
9:345:29474:16:22:72:537:231:121:g_d0_f3:121:g_d0_f2:B:entered one of the 48 groups.  Revenue to MA plans for persons in a given HCC or combination of HCC’s 
9:346:29576:22:8:71:218:209:121:g_d0_f2:121:g_d0_f2:B:                                                            
9:347:29636:8:12:72:424:201:42:g_d0_f3:100:g_d0_f2:F:12 Because of medical management, a 1 percent difference could potentially be causal. 
9:348:29722:12:17:72:539:189:42:g_d0_f3:100:g_d0_f2:F:13 These results are consistent with Brown, et al.’s findings in their Figure 2.  Brown, et al., point out that the upper 
9:349:29844:17:12:71:525:172:100:g_d0_f3:100:g_d0_f2:F:part of the risk score distribution was unprofitable; however, this is based on TM spending patterns that do not 
9:350:29957:12:13:71:539:160:100:g_d0_f3:100:g_d0_f2:F:replicate in MA (Newhouse, et al., 2013).  In Newhouse (2013) we had cost data by HCC from 2 MA plans; in one of 
9:351:30070:13:12:71:522:147:100:g_d0_f3:100:g_d0_f2:F:them, but not the other, the profitability of a beneficiary fell monotonically with the risk score, consistent with 
9:352:30186:12:12:71:533:135:100:g_d0_f3:100:g_d0_f2:F:Brown, et al.  Brown, et al. interpret their results as consistent with the second model of plan selection, however, 
9:353:30303:12:7:71:449:123:100:g_d0_f3:100:g_d0_f2:F:we interpret them as consistent with the first model of plan selection, as we describe below. 
9:354:30397:7:17:72:523:116:42:g_d0_f3:100:g_d0_f2:F:14 Even in 2006‐2007, however, about 10% more of MA beneficiaries, however, said their health had worsened 
9:355:30504:17:8:71:175:99:100:g_d0_f3:100:g_d0_f2:F:relative to the prior year. 
9:356:30532:8:17:72:529:91:42:g_d0_f3:100:g_d0_f2:F:15 Any improvement in medical management techniques, the expected direction of any change, would mean the 
9:357:30638:17:0:71:270:74:100:g_d0_f3:100:g_d0_f2:F:inference of reduced selection was understated. 
10:358:30686:0:15:72:531:709:121:g_d0_f3:121:g_d0_f2:B:is approximately proportional to what TM pays for these HCC’s or combinations of HCC’s.  Because the 
10:359:30787:15:16:71:513:694:121:g_d0_f3:121:g_d0_f2:B:plan had a varying ability to influence cost in these various disease categories and because it faced 
10:360:30889:16:15:71:537:678:121:g_d0_f3:121:g_d0_f2:B:varying degrees of market power across physicians who treated different diseases, its margins varied by 
10:361:30993:15:16:71:529:663:121:g_d0_f3:121:g_d0_f2:B:160 percentage points over these categories, which would appear to give it strong incentives to select 
10:362:31096:16:15:71:487:647:121:g_d0_f3:121:g_d0_f2:B:by HCC category.16  Nonetheless, there was almost no difference between the distribution of 
10:363:31188:15:16:71:531:632:121:g_d0_f3:121:g_d0_f2:B:beneficiaries across these 48 categories in the MA plan and the distribution in TM.  The mean absolute 
10:364:31291:16:15:71:538:616:121:g_d0_f3:121:g_d0_f2:B:difference in the share of beneficiaries in MA and TM across the 48 categories was only 0.34 percentage 
10:365:31395:15:15:71:530:601:121:g_d0_f3:121:g_d0_f2:B:points.  In this one plan at least, there was no evidence that, post risk adjustment and lock‐in changes, 
10:366:31501:15:16:71:502:586:121:g_d0_f3:121:g_d0_f2:B:the plan was structuring its product to attract beneficiaries in the relatively more profitable HCC 
10:367:31601:16:25:71:122:570:121:g_d0_f3:121:g_d0_f2:B:categories. 
10:368:31613:25:26:107:276:545:121:g_d0_f4:121:g_d0_f5:A:But What Happened to Profitability? 
10:369:31649:26:15:107:516:519:121:g_d0_f3:121:g_d0_f2:A:Although the earlier literature suggested that in the 1990’s plans benefited financially from 
10:370:31743:15:16:71:523:504:121:g_d0_f3:121:g_d0_f2:B:favorable selection, the results just cited do not answer the question of whether plans changed their 
10:371:31845:16:15:71:517:488:121:g_d0_f3:121:g_d0_f2:B:selection mechanism as the new HCC risk adjustment phased in such a way that they maintained or 
10:372:31941:15:16:71:536:473:121:g_d0_f3:121:g_d0_f2:B:enhanced their profit.  As Brown, et al. (2011) point out, after the implementation of the HCC system, it 
10:373:32047:16:15:71:540:457:121:g_d0_f3:121:g_d0_f2:B:was profitable for plans to select within an HCC category rather than simply select low utilizers within an 
10:374:32155:15:15:71:511:442:121:g_d0_f3:121:g_d0_f2:B:age‐sex category.  Brown, et al. present empirical evidence that plans did change their behavior in 
10:375:32255:15:16:71:536:427:121:g_d0_f3:121:g_d0_f2:B:exactly this fashion.  In the remainder of this paper we describe Brown’s basis for this claim and then re‐
10:376:32362:16:25:72:459:411:121:g_d0_f3:121:g_d0_f2:B:estimate their key equation on a much larger data set and more targeted population.   
10:377:32448:25:16:107:520:386:121:g_d0_f3:121:g_d0_f2:A:Brown, et al. estimated the following two equations using data from 1994 to 2007.  The two 
10:378:32539:16:15:71:535:370:121:g_d0_f3:121:g_d0_f2:B:equations compare the risk score and Medicare spending for persons in TM who switch from TM to MA 
10:379:32637:15:16:71:500:355:121:g_d0_f3:121:g_d0_f2:B:for some part of the following year with those who do not switch to MA and remain in TM.  The 
10:380:32731:16:15:71:541:339:121:g_d0_f3:121:g_d0_f2:B:question of interest is whether those opting for MA at the end of 2003, and so starting MA enrollment in 
10:381:32836:15:16:71:530:324:121:g_d0_f3:121:g_d0_f2:B:2004, differ in their use (relative to stayers in TM) from those opting for MA in prior years. The sample 
10:382:32942:16:15:71:510:308:121:g_d0_f3:121:g_d0_f2:B:Brown, et al. use comes from Medicare claims that are linked to the Medicare Current Beneficiary 
10:383:33039:15:15:71:534:293:121:g_d0_f3:121:g_d0_f2:B:Survey (MCBS) and is limited to persons who were in TM in year t since no analogous data are available 
10:384:33142:15:26:71:186:278:121:g_d0_f3:121:g_d0_f2:B:for those enrolled in MA. 
10:385:33168:26:15:107:177:252:121:g_d0_f7:121:g_d0_f7:A:݁ݎ݋ܿܵ	݇ݏܴ݅௜௧ൌ
10:386:33181:15:14:72:310:237:121:g_d0_f7:121:g_d0_f7:C:ߙ	଴ߙ	൅ଵܣܯ	݊݅	ݐ݊݁݌ܵ	ݎܻܽ݁	ݐݔ݁ܰ	݂݋	݊݋݅ݐܿܽݎܨ௧ାଵ൅
10:387:33225:14:26:72:479:223:121:g_d0_f7:121:g_d0_f8:C:ߙ	ଶܣܯ	݊݅	ݐ݊݁݌ܵ	ݎܻܽ݁	ݐݔ݁ܰ	݂݋	݊݋݅ݐܿܽݎܨ௜,௧ାଵ2002	ݎ݁ݐ݂ܣ	ݔ௧ߙ	൅ଷݏ݁݅݉݉ݑܦ	ݎܻܽ݁௧߳	൅௜௧ 
10:388:33302:26:16:107:109:197:121:g_d0_f8:121:g_d0_f8:A: 
10:389:33303:16:21:71:73:181:121:g_d0_f8:121:g_d0_f8:C: 
10:390:33304:21:8:71:218:160:121:g_d0_f2:121:g_d0_f2:B:                                                            
10:391:33364:8:17:72:518:152:42:g_d0_f3:100:g_d0_f2:F:16 For example, the least profitable diagnosis for the plan was unstable angina and other acute ischemic heart 
10:392:33475:17:12:71:533:135:100:g_d0_f3:100:g_d0_f2:F:disease where medical intervention by the plan would be minimal because of the acute nature of the treatment.  
10:393:33586:12:12:71:532:123:100:g_d0_f3:100:g_d0_f2:F:Similarly diseases typically treated by specialists, such as cancer and multiple sclerosis, were much less profitable 
10:394:33704:12:12:72:520:111:100:g_d0_f3:100:g_d0_f2:F:than chronic diseases typically treated by primary care physicians such as diabetes.  Specialists, being fewer in 
10:395:33818:12:13:71:535:99:100:g_d0_f3:100:g_d0_f2:F:number, have more market power vis‐à‐vis plans than do primary care physicians.  Although an unknown amount 
10:396:33926:13:12:71:537:86:100:g_d0_f3:100:g_d0_f2:F:of the 160 point spread across conditions is attributable to sampling error, there is a clear pattern in the more and 
10:397:34044:12:0:71:409:74:100:g_d0_f3:100:g_d0_f2:F:less profitable diagnoses, suggesting the variation by diagnosis is not merely noise. 
11:398:34130:0:15:108:153:709:121:g_d0_f7:121:g_d0_f7:A:$	ݒ݋ܩ௜௧ൌ
11:399:34138:15:15:72:311:694:121:g_d0_f7:121:g_d0_f7:C:ߚ	଴ߚ൅ଵܣܯ	݊݅	ݐ݊݁݌ܵ	ݎܻܽ݁	ݐݔ݁ܰ	݂݋	݊݋݅ݐܿܽݎܨ௜,௧ାଵ൅
11:400:34183:15:16:71:537:679:121:g_d0_f7:121:g_d0_f7:C:ߚ	ଶܣܯ	݊݅	ݐ݊݁݌ܵ	ݎܻܽ݁	ݐݔ݁ܰ	݂݋	݊݋݅ݐܿܽݎܨ௜,௧ାଵ2002	ݎ݁ݐ݂ܣ	ݔ௧ߚ	൅ଷߚ൅ݏ݁݅݉݉ݑܦ	ݎܻܽ݁ସ݁ݎ݋ܿܵ	݇ݏܴ݅௜௧൅
11:401:34269:16:15:71:90:663:121:g_d0_f7:121:g_d0_f8:C:ߝ	௜௧	 
11:402:34275:15:25:72:74:648:121:g_d0_f2:121:g_d0_f2:B: 
11:403:34276:25:16:72:540:623:121:g_d0_f3:121:g_d0_f2:B:In both equations Risk Scoreit is the CMS‐HCC value for beneficiary i in year t, and in the second equation 
11:404:34384:16:15:71:543:607:121:g_d0_f6:121:g_d0_f2:B:Gov $it is TM spending on beneficiary i in year t, including any out‐of‐pocket spending by the beneficiary.  
11:405:34493:15:16:71:520:592:121:g_d0_f6:121:g_d0_f2:B:Gov $it is thus a measure of how sick the beneficiary is in year t.  After 2002 takes the value 1 for the 
11:406:34599:16:25:71:268:576:121:g_d0_f3:100:g_d0_f2:C:years 2003 and later and is zero otherwise.  
11:407:34644:25:16:108:531:551:121:g_d0_f3:121:g_d0_f2:A:It is easiest to interpret these equations if one simply assumes that those who switched to MA 
11:408:34739:16:15:71:519:535:121:g_d0_f3:121:g_d0_f2:B:spent the entire next year in MA so that the fraction of the next year spent in MA is 1 for those who 
11:409:34841:15:16:71:535:520:121:g_d0_f3:121:g_d0_f2:B:switched and zero for those who did not.  Then for those who switched into MA for 1995, the risk score 
11:410:34944:16:15:71:533:504:121:g_d0_f3:121:g_d0_f2:B:based on the diagnoses recorded in TM in 1994 is ߙ଴ߙ൅ଵ, whereas for those who remained in TM it is 
11:411:35043:15:15:71:528:489:121:g_d0_f3:121:g_d0_f2:B:just ߙ଴. For subsequent years one simply adds the coefficient of the year dummy to both groups, with 
11:412:35144:15:16:71:513:474:121:g_d0_f3:121:g_d0_f2:B:an additional effect for the MA group in the After 2002 years.  Consistent with the results from the 
11:413:35245:16:15:71:540:458:121:g_d0_f3:121:g_d0_f2:B:literature cited above showing favorable selection in the 1990’s, Brown et al. find ߙଵ negative and highly 
11:414:35352:15:16:71:540:443:121:g_d0_f3:121:g_d0_f2:B:significant in the first equation, indicating that those who switched to MA had a lower risk score when in 
11:415:35459:16:25:71:454:427:121:g_d0_f3:121:g_d0_f2:B:TM and presumptively spent less.  We also found this result (Newhouse, et al., 2012). 
11:416:35545:25:16:107:535:402:121:g_d0_f3:121:g_d0_f2:A:The results of estimating the second equation are of greater interest since the second equation 
11:417:35641:16:15:71:540:386:121:g_d0_f3:121:g_d0_f2:B:not only measures total Medicare spending but also controls for the risk score, which was used to adjust 
11:418:35746:15:16:71:502:371:121:g_d0_f3:121:g_d0_f2:B:payments to plans starting in 2004.  Gov $it, the total spending by  TM beneficiaries in 1994 who 
11:419:35844:16:15:71:534:355:121:g_d0_f3:121:g_d0_f2:B:switched to MA in 1995 is ߚ଴ߚ	൅ଵ, and starting in 2003 it is  ߚ଴ߚ	൅ଵߚ	൅ଶ plus a year fixed effect that 
11:420:35947:15:15:71:536:340:121:g_d0_f3:121:g_d0_f2:B:applies to both switchers and stayers.  Brown, et al.’s test of whether the spending for those who chose 
11:421:36052:15:16:71:535:325:121:g_d0_f3:121:g_d0_f2:B:to switch into MA in the years 2003 and later (and so were in MA in 2004 and later) differed from those 
11:422:36156:16:15:71:540:309:121:g_d0_f3:121:g_d0_f2:B:who chose switch in prior years is whether one can reject the hypothesis that ߚଶ = 0, since the transition 
11:423:36263:15:16:71:527:294:121:g_d0_f3:121:g_d0_f2:B:to the HCC system began in 2004. They estimate ߚଶ to be negative with a t‐statistic of 2.02.  Since risk 
11:424:36368:16:15:71:506:278:121:g_d0_f3:121:g_d0_f2:B:score is controlled for, Brown, et al. interpret this as indicating that plans changed their selection 
11:425:36471:15:16:71:526:263:121:g_d0_f3:121:g_d0_f2:B:behavior to select those within HCC who were spending less in TM the year before they joined an MA 
11:426:36570:16:25:71:102:247:121:g_d0_f3:121:g_d0_f2:B:plan.   
11:427:36578:25:16:107:532:222:121:g_d0_f3:121:g_d0_f2:A:Brown, et al.’s use of claim files linked to the MCBS severely limits their sample size.  There are 
11:428:36678:16:15:71:529:206:121:g_d0_f3:121:g_d0_f2:B:about 16,000 observations per year in total in the MCBS.  The share in TM varies over the time period, 
11:429:36781:15:15:71:518:191:121:g_d0_f3:121:g_d0_f2:B:but averages around 90% in the pre‐HCC period and somewhat less in the post‐period.  Of that 90% 
11:430:36878:15:16:71:536:176:121:g_d0_f3:121:g_d0_f2:B:about 1‐4 percent switch into MA in a given year, or about 150‐600 per year, which is likely why Brown, 
11:431:36982:16:15:71:527:160:121:g_d0_f3:121:g_d0_f2:B:et al pooled the nine years before the introduction of the HCC’s to compare with the four subsequent 
11:432:37083:15:22:71:524:145:121:g_d0_f3:121:g_d0_f2:B:years.17  As we described earlier, the incentives to select varied by year during the 2004‐2007 period, 
11:433:37187:22:7:71:218:123:121:g_d0_f2:121:g_d0_f2:B:                                                            
11:434:37247:7:17:72:527:116:42:g_d0_f3:100:g_d0_f2:F:17 Note that this averages to only about 2‐8 persons per HCC per year.  Although the original specification of the 
11:435:37362:17:13:71:534:99:100:g_d0_f3:100:g_d0_f2:F:CMS‐HCC model included 189 HCC’s, only 70 were ultimately used in the risk adjustment scheme, presumably for 
11:436:37471:13:12:71:512:86:100:g_d0_f3:100:g_d0_f2:F:reasons of precision (Pope, et al., 2004).  Beneficiaries with multiple diseases typically have weights for each 
11:437:37584:12:0:71:502:74:100:g_d0_f3:100:g_d0_f2:F:disease added to arrive at a risk score, although there are a handful of one‐way interactions in the model. 
12:438:37692:0:15:72:536:709:121:g_d0_f3:121:g_d0_f2:B:that is, these four years encompassed the transition to the HCC method. To obtain greater precision we 
12:439:37795:15:16:71:525:694:121:g_d0_f3:121:g_d0_f2:B:re‐estimated Brown, et al.’s equations using the much larger 20% random sample of Medicare claims 
12:440:37893:16:25:71:300:678:121:g_d0_f3:121:g_d0_f2:B:from each calendar year in the 2001‐2011 period.   
12:441:37944:25:16:107:527:653:121:g_d0_f3:121:g_d0_f2:A:Brown, et al. include all TM enrollees in their sample, but we limit our sample to those whose 
12:442:38039:16:15:71:521:637:121:g_d0_f3:121:g_d0_f2:B:original reason for Medicare eligibility was old age, thus excluding beneficiaries who became eligible 
12:443:38142:15:16:71:516:622:121:g_d0_f3:121:g_d0_f2:B:before 65 for reasons of disability or having End Stage Renal Disease.  Table 1 shows that the group 
12:444:38243:16:15:71:534:606:121:g_d0_f3:121:g_d0_f2:B:whose original reason for eligibility was old age comprises 79% of Medicare beneficiaries.  We focus on 
12:445:38347:15:15:71:534:591:121:g_d0_f3:121:g_d0_f2:B:the group that became eligible from turning 65 because it comprises the bulk of Medicare beneficiaries 
12:446:38450:15:16:71:534:576:121:g_d0_f3:121:g_d0_f2:B:and makes the population more homogeneous.  For the latter reason we also exclude the dual eligibles 
12:447:38551:16:15:71:528:560:121:g_d0_f3:121:g_d0_f2:B:and the institutionalized.  There are, however, additional reasons to exclude the dual eligibles and the 
12:448:38656:15:16:71:541:545:121:g_d0_f3:121:g_d0_f2:B:institutionalized.  The 2003 Medicare Modernization Act created separate Special Needs Plans (SNPs) for 
12:449:38760:16:15:71:541:529:121:g_d0_f3:121:g_d0_f2:B:the duals, the institutionalized, and those with certain chronic conditions as part of the MA program.18     
12:450:38869:15:16:72:532:514:121:g_d0_f3:121:g_d0_f2:B:Thus, legislative authorization for these plans did not exist until 2003, so the menu of choices for these 
12:451:38976:16:15:71:528:498:121:g_d0_f3:121:g_d0_f2:B:two groups expanded coincident with the introduction of the HCC’s.  Moreover, the lock‐in provisions 
12:452:39077:15:16:71:507:483:121:g_d0_f3:121:g_d0_f2:B:that took effect in 2006 do not apply to duals, and the institutionalized are paid with a separately 
12:453:39178:16:25:72:239:467:121:g_d0_f3:121:g_d0_f2:B:estimated risk adjustment formula.    
12:454:39216:25:15:107:526:442:121:g_d0_f3:121:g_d0_f2:A:Descriptive data on the group we focus on is shown in Table 2; similar data on two groups we 
12:455:39309:15:16:71:518:427:121:g_d0_f3:121:g_d0_f2:B:exclude, the duals and the institutionalized, are shown in Tables 3 and 4.  As can be seen, these two 
12:456:39411:16:25:71:502:411:121:g_d0_f3:121:g_d0_f2:B:groups are both smaller and spend considerably more than the non‐institutionalized, non‐duals. 
12:457:39506:25:16:107:533:386:121:g_d0_f3:121:g_d0_f2:A:One type of plan that flourished between 2006 and 2010 was the private‐fee‐for‐service (PFFS) 
12:458:39600:16:15:71:511:370:121:g_d0_f3:121:g_d0_f2:B:plan.  Although this plan was paid like an MA plan, its characteristics are similar to TM.  PFFS plans 
12:459:39703:15:16:71:526:355:121:g_d0_f3:121:g_d0_f2:B:generally did not have networks, so that enrollees could see any provider who saw Medicare patients 
12:460:39803:16:15:71:519:339:121:g_d0_f3:121:g_d0_f2:B:without a differential out‐of‐pocket payment; the provider was paid at TM rates.19  Unlike other MA 
12:461:39903:15:16:71:541:324:121:g_d0_f3:121:g_d0_f2:B:plans, there was by law no medical management.  PFFS plans only had 80,000 enrollees in 2005 (and less 
12:462:40006:16:15:71:525:308:121:g_d0_f3:121:g_d0_f2:B:than half that in prior years), but grew to 800,000 in 2006, 1.5 million in 2007, 2.3 million in 2008, 2.4 
12:463:40113:15:15:71:538:293:121:g_d0_f3:121:g_d0_f2:B:million in 2009, and then began to decline because of a requirement that PFFS plans have networks that 
12:464:40216:15:16:71:511:278:121:g_d0_f3:121:g_d0_f2:B:took effect in 2011.20  In this period PFFS dominated TM for many beneficiaries (McWilliams, et al. 
12:465:40316:16:15:71:536:262:121:g_d0_f3:121:g_d0_f2:B:2011).  Because PFFS plans are both different from HMO and PPO plans but also because they attracted 
12:466:40417:15:16:71:537:247:121:g_d0_f3:121:g_d0_f2:B:many switchers in some years, we will show results including and excluding those who switched to PFFS 
12:467:40519:16:15:71:515:231:121:g_d0_f3:121:g_d0_f2:B:plans.  Tables 5 and 6 disaggregate the sample shown in Table 2 into those switching to HMO’s and 
12:468:40617:15:32:71:259:216:121:g_d0_f3:121:g_d0_f2:B:PPO’s versus those switching to PFFS.        
12:469:40662:32:7:71:218:184:121:g_d0_f2:121:g_d0_f2:B:                                                            
12:470:40722:7:17:72:525:177:42:g_d0_f3:100:g_d0_f2:F:18 These plans could have changed selection patterns among the dual eligibles and institutionalized.  Such plans 
12:471:40835:17:13:71:533:160:100:g_d0_f3:100:g_d0_f2:F:first entered the market in 2004, but there were only 11 such plans in that year, a number that grew to 125 plans 
12:472:40949:13:12:71:514:147:100:g_d0_f3:100:g_d0_f2:F:in 2005. The first enrollment data we have found are for 2006, when there were 276 SNP plans with 541,000 
12:473:41055:12:12:71:540:135:100:g_d0_f3:100:g_d0_f2:F:enrollees out of a total of 6.9 million MA enrollees.18 In 2006, 226 of the 276 plans were for dual eligibles, and they 
12:474:41175:12:12:71:515:123:100:g_d0_f3:100:g_d0_f2:F:had 440,000 enrollees (6% of all MA enrollees); there were also 37 plans for the institutionalized with 20,000 
12:475:41286:12:7:71:310:111:100:g_d0_f3:100:g_d0_f2:F:enrollees (Medicare Payment Advisory Commission 2007). 
12:476:41341:7:18:72:541:104:42:g_d0_f3:100:g_d0_f2:F:19 Starting in 2011 PFFS plans were required to have networks; at that time many transformed themselves into PPO 
12:477:41454:18:7:71:97:86:100:g_d0_f3:100:g_d0_f2:F:plans. 
12:478:41461:7:0:72:464:79:42:g_d0_f3:100:g_d0_f2:F:20 The enrollment data are from various reports of the Medicare Payment Advisory Commission. 
13:479:41554:0:15:108:535:709:121:g_d0_f3:121:g_d0_f2:A:The samples shown in Tables 1‐6 include only those who were enrolled in both Parts A and B of 
13:480:41648:15:16:71:540:694:121:g_d0_f3:121:g_d0_f2:B:Medicare in the prior year and who were enrolled in Medicare on January 1 of the succeeding year.  This 
13:481:41752:16:15:71:529:678:121:g_d0_f3:121:g_d0_f2:B:is necessary to allow us to identify those who switched from TM to MA, but it does exclude those who 
13:482:41853:15:16:71:535:663:121:g_d0_f3:121:g_d0_f2:B:died in the prior year.  They also exclude the relatively small numbers of beneficiaries in cost‐based MA 
13:483:41959:16:15:71:533:647:121:g_d0_f3:121:g_d0_f2:B:plans, because the reimbursement for such plans is based on their medical costs and is not fixed as it is 
13:484:42065:15:16:71:541:632:121:g_d0_f3:121:g_d0_f2:B:for most MA plans. Cost‐based plans enrolled 10% of enrollees in 1996, but only 4% in 2014 (Prospective 
13:485:42169:16:15:71:536:616:121:g_d0_f3:121:g_d0_f2:B:Payment Assessment Commission 1997; Centers for Medicare and Medicaid Services 2014).  Finally and 
13:486:42268:15:15:71:518:601:121:g_d0_f3:121:g_d0_f2:B:importantly, risk scores for new Medicare enrollees in MA are based only on demographic variables 
13:487:42366:15:16:71:515:586:121:g_d0_f3:121:g_d0_f2:B:because newly eligible Medicare beneficiaries have no prior claims information.  Lacking diagnostic 
13:488:42466:16:25:71:496:570:121:g_d0_f3:121:g_d0_f2:B:information for this group with which one could compute an HCC score, we also exclude them. 
13:489:42558:25:16:107:541:545:121:g_d0_f3:121:g_d0_f2:A:Three conclusions are immediately apparent from the data in Tables 1‐6.  First, as already noted, 
13:490:42656:16:15:71:531:529:121:g_d0_f3:121:g_d0_f2:B:the proportion of switchers in any given year is small.  Second, the raw means indicate risk adjustment 
13:491:42760:15:16:71:506:514:121:g_d0_f3:121:g_d0_f2:B:has a considerable burden if selection is to be mitigated; in the ten years shown in Table 2, mean 
13:492:42859:16:15:71:535:498:121:g_d0_f3:121:g_d0_f2:B:spending in TM among who switched to MA in the year before they switched was 17% to 34% less than 
13:493:42957:15:16:71:523:483:121:g_d0_f3:121:g_d0_f2:B:among the much larger group that remained in TM.  Third, the number of switchers among the duals 
13:494:43054:16:15:71:526:467:121:g_d0_f3:121:g_d0_f2:B:and the institutionalized is small in absolute terms, especially in the pre‐HCC years; in those years the 
13:495:43160:15:25:71:285:452:121:g_d0_f3:121:g_d0_f2:B:number of switchers to PFFS plans is also small. 
13:496:43209:25:16:107:524:427:121:g_d0_f3:121:g_d0_f2:A:The left hand panel Table 7 shows results from re‐estimating Brown, et al.’s second equation 
13:497:43302:16:15:71:539:411:121:g_d0_f3:121:g_d0_f2:B:using the sample shown in Table 2.  The key coefficients are those for Switched to MA the following year 
13:498:43407:15:16:71:538:396:121:g_d0_f3:121:g_d0_f2:B:and Switched to MA the following year*Year.  For those who were in TM in 2001 and switched to MA on 
13:499:43507:16:15:71:526:380:121:g_d0_f3:121:g_d0_f2:B:January 1, 2002, the Switched to MA coefficient indicates that they spent $174 less on average within 
13:500:43609:15:16:71:539:365:121:g_d0_f3:121:g_d0_f2:B:each HCC than those who remained in TM assuming they spent the full year in MA.  In 2002 this amount 
13:501:43710:16:15:71:500:349:121:g_d0_f3:121:g_d0_f2:B:increased to $393 (=174+219).  Using the data from Table 2, these amounts were 3‐6% of mean 
13:502:43802:15:16:71:506:334:121:g_d0_f3:121:g_d0_f2:B:spending in those years.  In 2003‐2005, as the HCC system was transitioning into place, favorable 
13:503:43900:16:15:71:520:318:121:g_d0_f3:121:g_d0_f2:B:selection within HCC increased, especially among those choosing to switch in 2004 and 2005.  These 
13:504:43999:15:15:71:508:303:121:g_d0_f3:121:g_d0_f2:B:results are consistent with Brown, et al.’s result that within‐HCC selection increased among those 
13:505:44098:15:26:71:272:288:121:g_d0_f3:121:g_d0_f2:B:choosing to enroll in MA in 2003 and later.    
13:506:44145:26:15:107:526:262:121:g_d0_f3:121:g_d0_f2:A:After 2005, however, selection fell, and from 2006‐2010, the years when the HCC system was 
13:507:44236:15:16:71:532:247:121:g_d0_f3:121:g_d0_f2:B:fully in place, the amount of selection within HCC was approximately the same as in 2001‐2002, before 
13:508:44338:16:15:71:520:231:121:g_d0_f3:121:g_d0_f2:B:the HCC system was implemented.  If one averages the within‐HCC selection for 2001‐2002, the two 
13:509:44435:15:16:71:536:216:121:g_d0_f3:121:g_d0_f2:B:years before the transition, the within‐HCC selection was $284; the analogous figure for 2006‐2010, the 
13:510:44539:16:15:71:540:200:121:g_d0_f3:121:g_d0_f2:B:five years after the system was fully in place, was $320.  The $36 difference between these two means is 
13:511:44644:15:26:71:309:185:121:g_d0_f3:121:g_d0_f2:B:well within one standard deviation of the difference. 
13:512:44698:26:15:107:536:159:121:g_d0_f3:121:g_d0_f2:A:Although the data in Table 7 suggest that in 2003‐2005 there was additional favorable selection 
13:513:44794:15:15:71:507:144:121:g_d0_f3:121:g_d0_f2:B:within HCC when compared with the pre‐HCC years, in those years there was 70%, 50%, and 25% 
13:514:44886:15:16:71:530:129:121:g_d0_f3:121:g_d0_f2:B:weight, respectively, on the old demographic system.  As a result, it may well not have been profitable 
13:515:44990:16:15:71:523:113:121:g_d0_f3:121:g_d0_f2:B:to select within HCC, especially in 2003 and 2004, because during these phase‐in years even low cost 
13:516:45091:15:0:71:527:98:121:g_d0_f3:121:g_d0_f2:B:patients in a high cost HCC likely would be more expensive than a patient with no HCC’s and so would 
14:517:45192:0:15:72:507:709:121:g_d0_f3:121:g_d0_f2:B:have reduced the plan’s profit.  We therefore do not regard the data for these transition years as 
14:518:45291:15:26:71:339:694:121:g_d0_f3:121:g_d0_f2:B:necessarily indicating that plans chose to select within HCC. 
14:519:45353:26:15:107:536:668:121:g_d0_f3:121:g_d0_f2:A:The right hand panel in Table 7 shows results for the same years using the old demographic risk 
14:520:45449:15:16:71:522:653:121:g_d0_f3:121:g_d0_f2:B:adjustment methods, that is, excluding the risk score but adjusting for age and gender.21  The results 
14:521:45552:16:15:72:529:637:121:g_d0_f3:121:g_d0_f2:B:show much greater selection from use of the old system.  When only age and gender are adjusted for, 
14:522:45652:15:16:71:526:622:121:g_d0_f3:121:g_d0_f2:B:those who remained in TM in 2001 and 2002 spent $1,689 and $2,239 (=1,689+550) more in TM than 
14:523:45747:16:15:71:520:606:121:g_d0_f3:121:g_d0_f2:B:those who switched, respectively.22  Thus, the comparison of the $1,689 and $2,239 values (average 
14:524:45846:15:15:71:519:591:121:g_d0_f3:121:g_d0_f2:B:$1,964) with the $320 figure from the years following full implementation of the HCC’s (Table 7, left 
14:525:45948:15:16:71:525:576:121:g_d0_f3:121:g_d0_f2:B:hand panel) indicates that the combination of the HCC risk adjustment system and the lock‐in greatly 
14:526:46049:16:25:71:156:560:121:g_d0_f3:121:g_d0_f2:B:reduced selection. 
14:527:46068:25:16:107:535:535:121:g_d0_f3:121:g_d0_f2:A:Although Table 7 contains our principal findings, we examined the robustness of our findings to 
14:528:46164:16:15:71:520:519:121:g_d0_f3:121:g_d0_f2:B:including as explanatory variables the MA penetration in the beneficiary’s county of residence and a 
14:529:46265:15:16:71:499:504:121:g_d0_f3:121:g_d0_f2:B:main effect for those who moved (Table 8).  The inclusion of these variables did not change our 
14:530:46361:16:15:71:522:488:121:g_d0_f3:121:g_d0_f2:B:qualitative conclusions, namely that at a given level of penetration, selection in the era before HCC’s 
14:531:46465:15:16:71:538:473:121:g_d0_f3:121:g_d0_f2:B:with only demographic adjusters was notably greater than in the era after implementation of the HCC’s, 
14:532:46568:16:15:71:530:457:121:g_d0_f3:121:g_d0_f2:B:and that selection within HCCs was little different among those who switched in the 2006‐2010 period 
14:533:46669:15:15:71:517:442:121:g_d0_f3:121:g_d0_f2:B:than it was in 2001 and 2002.  Interestingly, however, starting in 2002 the effect of a 10 percentage 
14:534:46771:15:16:71:527:427:121:g_d0_f3:121:g_d0_f2:B:point change in MA penetration in a county became monotonically more negative, a period when MA 
14:535:46867:16:15:71:536:411:121:g_d0_f3:121:g_d0_f2:B:enrollment was rising substantially, from around 15% of all beneficiaries in 2001‐2002 to around 24% in 
14:536:46971:15:16:71:529:396:121:g_d0_f3:121:g_d0_f2:B:2010‐2011.  The usual economic model of selection (Cutler and Reber 1998; Feldman and Dowd 1982) 
14:537:47068:16:15:71:536:380:121:g_d0_f3:121:g_d0_f2:B:suggests that an increase in penetration should attract worse risks into MA (as well as raise the average 
14:538:47174:15:16:71:523:365:121:g_d0_f3:121:g_d0_f2:B:risk in TM).  The data in Table 8 do not support this prediction; starting in 2005 the coefficient on the 
14:539:47280:16:15:71:541:349:121:g_d0_f3:121:g_d0_f2:B:penetration variable turns negative and becomes steadily more negative.  During this period penetration 
14:540:47384:15:16:71:537:334:121:g_d0_f3:121:g_d0_f2:B:rose nationally every year; the steadily more negative coefficients indicate that, if anything, increasingly 
14:541:47493:16:15:71:535:318:121:g_d0_f3:121:g_d0_f2:B:better risks were being attracted to MA as county‐level penetration increased in the cross section.  This 
14:542:47599:15:25:71:517:303:121:g_d0_f3:121:g_d0_f2:B:is consistent with a finding we had reached earlier using different methods (Newhouse et al. 2012). 
14:543:47699:25:16:107:537:278:121:g_d0_f3:121:g_d0_f2:A:As described above, PFFS plans differed considerably from HMO plans, and one might therefore 
14:544:47792:16:15:71:540:262:121:g_d0_f3:121:g_d0_f2:B:anticipate selection patterns would differ.  Hence, we reestimated the results in Table 7 using only those 
14:545:47899:15:16:71:541:247:121:g_d0_f3:121:g_d0_f2:B:who switched to HMO plans.23   These results are shown in Table 9.  We were unable to identify whether 
14:546:48002:16:15:71:533:231:121:g_d0_f3:121:g_d0_f2:B:the plan was a PFFS or an HMO plan for those who switched in 2010, so Table 9 has once less post‐HCC 
14:547:48103:15:16:71:538:216:121:g_d0_f3:121:g_d0_f2:B:year than Table 7.  The average switcher in the 3 post‐HCC years shown in Table 9 spent $365 less in TM 
14:548:48207:16:15:71:519:200:121:g_d0_f3:121:g_d0_f2:B:the year prior to the switch, compared with the $320 figure in Table 6.  This difference of $45 is also 
14:549:48311:15:16:71:524:185:121:g_d0_f3:121:g_d0_f2:B:within one standard error; thus, our findings are robust to considering just those who switch to HMO 
14:550:48412:16:21:71:320:169:121:g_d0_f3:121:g_d0_f2:B:and PPO plans rather than all MA plans, including PFFS. 
14:551:48468:21:8:71:218:148:121:g_d0_f2:121:g_d0_f2:B:                                                            
14:552:48528:8:17:72:514:140:42:g_d0_f3:100:g_d0_f2:F:21 The earlier formula also adjusted for Medicaid and institutionalized status, but those groups are not in our 
14:553:48640:17:7:71:105:123:100:g_d0_f3:100:g_d0_f2:F:sample. 
14:554:48648:7:17:72:540:116:42:g_d0_f3:100:g_d0_f2:F:22 Although the earlier system also used Medicaid eligibility and institutional status to risk adjust, this sample omits 
14:555:48769:17:8:71:340:99:100:g_d0_f3:100:g_d0_f2:F:those two groups and thus we only adjust using age and gender.   
14:556:48834:8:17:72:529:91:42:g_d0_f3:100:g_d0_f2:F:23 Very few persons switched to PFFS in 2001 and 2002 (Table 6) so that comparisons of pre‐ and post HCC years 
14:557:48945:17:0:71:131:74:100:g_d0_f3:100:g_d0_f2:F:are imprecise. 
15:558:48960:0:15:108:539:709:121:g_d0_f3:121:g_d0_f2:A:We suggested above that the more unique physicians a beneficiary anticipated seeing, the more 
15:559:49054:15:16:71:535:694:121:g_d0_f3:121:g_d0_f2:B:likely the beneficiary would prefer TM because it would be more likely that they would want to use out‐
15:560:49157:16:15:71:507:678:121:g_d0_f3:121:g_d0_f2:B:of‐network physicians if they enrolled in MA.  Table 10 shows that the average number of unique 
15:561:49253:15:16:71:511:663:121:g_d0_f3:121:g_d0_f2:B:physicians seen by a beneficiary rises monotonically with the number of HCC’s.  Thus, the costliest 
15:562:49353:16:25:71:451:647:121:g_d0_f3:121:g_d0_f2:B:beneficiaries within an HCC may inherently prefer the greater provider choice in TM. 
15:563:49438:25:26:107:164:622:121:g_d0_f4:121:g_d0_f2:A:Conclusions 
15:564:49450:26:26:107:229:596:121:g_d0_f3:121:g_d0_f2:A:We have two main results: 
15:565:49476:26:15:125:523:570:121:g_d0_f9:121:g_d0_f2:A: Although there appears to be selection within HCC that favors MA, the magnitude of 
15:566:49560:15:16:143:521:555:121:g_d0_f3:121:g_d0_f2:A:this selection is little changed from the period two years before the HCC system was 
15:567:49645:16:16:143:408:539:121:g_d0_f3:121:g_d0_f2:A:introduced to the five years following its full introduction.   
15:568:49709:16:15:125:531:523:121:g_d0_f9:121:g_d0_f2:?: Although some favorable selection into MA appears to remain, the introduction of the 
15:569:49795:15:15:143:522:508:121:g_d0_f3:121:g_d0_f2:A:HCC system and the lock‐in has markedly diminished it.  Since these two innovations 
15:570:49879:15:16:143:533:493:121:g_d0_f3:121:g_d0_f2:A:were introduced at approximately the same time, we have not tried to decompose the 
15:571:49962:16:15:143:531:477:121:g_d0_f3:121:g_d0_f2:A:amount of reduction attributable to each.  This decrease in selection is consistent with 
15:572:50051:15:16:143:534:462:121:g_d0_f3:121:g_d0_f2:A:other evidence (Newhouse, et al. 2012; Newhouse et al. 2013; Newhouse and McGuire 
15:573:50133:16:15:143:179:446:121:g_d0_f3:121:g_d0_f2:A:2014).   
15:574:50142:15:16:143:145:431:121:g_d0_f2:121:g_d0_f2:A: 
15:575:50143:16:15:107:544:415:121:g_d0_f3:121:g_d0_f2:A:A key policy question, of course, is the magnitude of the remaining selection in the MA program.  
15:576:50241:15:15:72:490:400:121:g_d0_f3:121:g_d0_f2:B:How much should these findings influence one’s judgment on that question?  Given the small 
15:577:50332:15:16:71:532:385:121:g_d0_f3:121:g_d0_f2:B:proportion of beneficiaries who switch from TM to MA in a given year relative to the stock of enrollees 
15:578:50436:16:15:71:502:369:121:g_d0_f3:121:g_d0_f2:B:in TM, one to four percent of all beneficiaries, we think rather little.  Because of status quo bias, 
15:579:50538:15:16:71:528:354:121:g_d0_f3:121:g_d0_f2:B:beneficiaries tend to remain in the plan they selected, and over time there is regression to the mean.  
15:580:50642:16:15:71:531:338:121:g_d0_f3:121:g_d0_f2:B:Stated differently, the longer that beneficiaries remain in TM or MA, concerns about the effects of any 
15:581:50746:15:16:71:523:323:121:g_d0_f3:121:g_d0_f2:B:initial differential selection are mitigated.  For example, age‐sex‐Medicaid adjusted mortality in 2008 
15:582:50850:16:15:72:536:307:121:g_d0_f3:121:g_d0_f2:B:was 13 percent less after in the year immediately after enrolling in MA compared with mortality among 
15:583:50952:15:16:71:535:292:121:g_d0_f3:121:g_d0_f2:B:those who stayed in TM, but for those who have been in MA five years or more, adjusted mortality was 
15:584:51053:16:15:71:515:276:121:g_d0_f3:121:g_d0_f2:B:an insignificant one percent less relative to those who stayed in TM.  In addition, McWilliams, et al. 
15:585:51156:15:15:71:488:261:121:g_d0_f3:121:g_d0_f2:B:(2012) made a straightforward comparisons of self‐rated health status among all TM and MA 
15:586:51246:15:16:71:527:246:121:g_d0_f3:121:g_d0_f2:B:beneficiaries, not just those in TM who switched compared with those who did not.  That comparison 
15:587:51345:16:15:71:530:230:121:g_d0_f3:121:g_d0_f2:B:showed that the proportion of MA beneficiaries who rated their health fair or poor was notably less in 
15:588:51448:15:16:71:537:215:121:g_d0_f3:121:g_d0_f2:B:MA in 2001‐2003, in the pre‐HCC and lock‐in era, but that it had converged toward the TM rate by 2006‐
15:589:51550:16:25:71:473:199:121:g_d0_f3:121:g_d0_f2:B:2007.  Thus, the mix of risks overall among all those enrolled in MA and TM may be close. 
15:590:51640:25:16:107:527:174:121:g_d0_f3:121:g_d0_f2:A:We return now to the two types of selection identified in the health economics literature and 
15:591:51734:16:15:71:510:158:121:g_d0_f3:121:g_d0_f2:B:the associated inefficiencies, and consider what our results mean in those terms.  The first type of 
15:592:51835:15:16:71:512:143:121:g_d0_f3:121:g_d0_f2:B:selection problem is when individuals sort themselves inefficiently between plan types, due to the 
15:593:51934:16:15:71:517:127:121:g_d0_f3:121:g_d0_f2:B:premium for the more generous plan being “too high” because more costly types are more likely to 
15:594:52031:15:15:71:533:112:121:g_d0_f3:121:g_d0_f2:B:prefer the more generous coverage.  The premium thus reflects the average incremental cost between 
15:595:52130:15:16:71:541:97:121:g_d0_f3:121:g_d0_f2:B:plans (as it needs to for efficiency) but also a component due to selection (which interferes with efficient 
15:596:52239:16:0:71:516:81:121:g_d0_f3:121:g_d0_f2:B:sorting).  When risk adjustors better track expected costs, as we found evidence for here, premium 
16:597:52338:0:15:72:534:709:121:g_d0_f3:121:g_d0_f2:B:differences between plans in a competitive market will contain less of a component due to selection.24  
16:598:52442:15:16:71:495:694:121:g_d0_f3:121:g_d0_f2:B:Thus, our findings suggest that inefficiencies in plan choices in Medicare Advantage have likely 
16:599:52539:16:15:71:521:678:121:g_d0_f3:121:g_d0_f2:B:diminished.  It is worth keeping in mind, however, that any single premium cannot sort beneficiaries 
16:600:52640:15:16:71:535:663:121:g_d0_f3:121:g_d0_f2:B:efficiently so some selection problems of this first type would remain even if selection as we measure it 
16:601:52746:16:15:71:532:647:121:g_d0_f3:121:g_d0_f2:B:here were completely eliminated (McGuire, et al. 2013).  Efficient plan choice of premium and benefits 
16:602:52849:15:16:71:532:632:121:g_d0_f3:121:g_d0_f2:B:may also be interfered with by institutional rules that discourage plans from deviating from a premium 
16:603:52952:16:15:71:535:616:121:g_d0_f3:121:g_d0_f2:B:exactly equal to the mandatory Part B premium automatically paid by all beneficiaries who elect an MA 
16:604:53054:15:25:71:237:601:121:g_d0_f3:121:g_d0_f2:B:plan (Newhouse and McGuire 2014). 
16:605:53088:25:16:107:526:576:121:g_d0_f3:121:g_d0_f2:A:The second type of selection occurs when plans distort their mix of premiums and benefits to 
16:606:53181:16:15:71:536:560:121:g_d0_f3:121:g_d0_f2:B:attract profitable enrollees.  The new risk adjustment system greatly changed plans’ financial incentives 
16:607:53287:15:16:71:541:545:121:g_d0_f3:121:g_d0_f2:B:to favor low cost beneficiaries within an HCC rather than low cost beneficiaries within an age‐sex group.  
16:608:53394:16:15:71:534:529:121:g_d0_f3:121:g_d0_f2:B:Our first conclusion suggests that plans did not alter their selection behavior in response to this change 
16:609:53501:15:16:71:530:514:121:g_d0_f3:121:g_d0_f2:B:in incentive.  We find this conclusion plausible; while plans choose networks, formularies, cost‐sharing 
16:610:53606:16:15:71:506:498:121:g_d0_f3:121:g_d0_f2:B:structure, and marketing, under the new system they would have to motivate the physicians and 
16:611:53700:15:16:71:537:483:121:g_d0_f3:121:g_d0_f2:B:hospitals with whom they contract to select profitable patients within an HCC, and it is not obvious how 
16:612:53805:16:15:71:535:467:121:g_d0_f3:121:g_d0_f2:B:plans, who mostly have arms‐length contracts with hospitals and physicians, would do that.  It certainly 
16:613:53910:15:15:71:511:452:121:g_d0_f3:121:g_d0_f2:B:is conceivable that a plan could form networks of providers who happen to have low cost patients 
16:614:54007:15:16:71:541:437:121:g_d0_f3:121:g_d0_f2:B:within a diagnosis at a given point in time, but given the randomness in spending among a given panel of 
16:615:54112:16:15:71:510:421:121:g_d0_f3:121:g_d0_f2:B:patients at the provider level along with the turnover in patients at any given provider or provider 
16:616:54213:15:16:71:508:406:121:g_d0_f3:121:g_d0_f2:B:group, providers that appear to be low cost today may be high cost tomorrow (Hofer, et al. 1999; 
16:617:54310:16:15:71:541:390:121:g_d0_f3:121:g_d0_f2:B:Bronskill, et al. 2002).  Also the more stringent lock‐in periods may have inhibited some plan switching in 
16:618:54418:15:26:71:234:375:121:g_d0_f3:121:g_d0_f2:B:response to health status changes.   
16:619:54455:26:15:107:531:349:121:g_d0_f3:121:g_d0_f2:A:Furthermore, in other work we failed to find evidence of selection across HCC’s (Newhouse, et 
16:620:54549:15:16:71:532:334:121:g_d0_f3:121:g_d0_f2:B:al. 2013).  It seems plausible that it is less costly to select across HCC’s than within HCC, since networks 
16:621:54658:16:15:71:520:318:121:g_d0_f3:121:g_d0_f2:B:and formularies might be structured to attract or not attract individuals with certain diagnoses.  Our 
16:622:54761:15:15:71:508:303:121:g_d0_f3:121:g_d0_f2:B:failure to find this type of selection with the HCC system in place strengthens our confidence that 
16:623:54861:15:26:71:358:288:121:g_d0_f3:121:g_d0_f2:B:selection mechanisms did not change in response to the HCC’s.  
16:624:54924:26:15:107:505:262:121:g_d0_f3:121:g_d0_f2:A:One other phenomenon may explain some remaining selection.  Newhouse, et al. (2012) 
16:625:55008:15:16:71:528:247:121:g_d0_f3:121:g_d0_f2:B:showed that more than half of those who disenrolled from Medicare Advantage re‐enrolled within 12 
16:626:55106:16:15:71:518:231:121:g_d0_f3:121:g_d0_f2:B:months from disenrolling.  This is consistent with beneficiary provider shopping: when a beneficiary 
16:627:55207:15:16:71:514:216:121:g_d0_f3:121:g_d0_f2:B:wants a medical procedure performed by an out‐of‐network provider, they switch to TM to have it 
16:628:55303:16:15:71:532:200:121:g_d0_f3:121:g_d0_f2:B:done, and then re‐enroll in the MA plan, for example, a hip replacement done by a particular surgeon.  
16:629:55406:15:16:71:522:185:121:g_d0_f3:121:g_d0_f2:B:Although the lock‐in could have reduced such provider shopping, this type of behavior may plausibly 
16:630:55506:16:15:71:534:169:121:g_d0_f3:121:g_d0_f2:B:have been approximately constant before and after the HCC system and the lock‐in, that is, it is related 
16:631:55611:15:18:71:473:154:121:g_d0_f3:121:g_d0_f2:B:to the inherent difference between TM and MA of freedom of provider choice within TM. 
16:632:55697:18:8:71:218:136:121:g_d0_f2:121:g_d0_f2:B:                                                            
16:633:55757:8:17:72:524:128:42:g_d0_f3:100:g_d0_f2:F:24 Although premiums and cost sharing for TM are set administratively, the expected cost of MA premiums and 
16:634:55865:17:12:71:530:111:100:g_d0_f3:100:g_d0_f2:F:cost sharing is constrained to equal to or less than TM’s actuarial value.  In practice by 2007 the expected cost of 
16:635:55982:12:13:71:529:99:100:g_d0_f3:100:g_d0_f2:F:MA was less for almost all beneficiaries (McWilliams, et al., 2011).  Thus, this constraint on the actuarial value of 
16:636:56100:13:12:71:181:86:100:g_d0_f3:100:g_d0_f2:F:MA plans is rarely binding. 
16:637:56128:12:0:71:73:74:100:g_d0_f2:100:g_d0_f2:F: 
17:638:56129:0:15:108:527:709:121:g_d0_f3:121:g_d0_f2:A:Balancing profitability across groups of beneficiaries according to their health care use, as the 
17:639:56227:15:16:71:526:694:121:g_d0_f3:121:g_d0_f2:B:HCC system seeks to do, is likely to mitigate incentives to distort certain services in relation to others, 
17:640:56335:16:15:71:524:678:121:g_d0_f3:121:g_d0_f2:B:but our findings do not allay concerns about the basic incentives to reduce premiums and benefits to 
17:641:56436:15:16:71:528:663:121:g_d0_f3:121:g_d0_f2:B:attract profitable types.  Nonetheless, in contrast to the basic Rothschild‐Stiglitz model where there is 
17:642:56542:16:15:71:527:647:121:g_d0_f3:121:g_d0_f2:B:no regulator and no constraint on contracts that can be offered, Medicare has numerous instruments 
17:643:56641:15:26:71:490:632:121:g_d0_f3:121:g_d0_f2:B:with which to address selection and it appears to have made substantial progress in doing so. 
17:644:56735:26:15:71:538:606:121:g_d0_f2:121:g_d0_f2:B: In sum, improving the match between risk adjusted payments and expected costs in MA is likely 
17:645:56830:15:15:71:525:591:121:g_d0_f3:121:g_d0_f2:B:to have improved the efficiency of the MA program, both in terms of efficient sorting of beneficiaries 
17:646:56933:15:16:71:536:576:121:g_d0_f3:121:g_d0_f2:B:between TM and MA and in terms of the nature of plan offerings.  Efficiency problems would, however, 
17:647:57034:16:15:71:512:560:121:g_d0_f3:121:g_d0_f2:B:persist even with a complete elimination of selection as studied here because of Medicare’s single 
17:648:57133:15:16:71:538:545:121:g_d0_f3:121:g_d0_f2:B:premium policy.  Attention to premium policy as well as risk‐adjustment policy is called for to more fully 
17:649:57240:16:0:71:546:529:121:g_d0_f3:121:g_d0_f2:B:address performance of the MA program.  
18:650:57280:0:25:108:110:709:121:g_d0_f2:121:g_d0_f2:A: 
18:651:57281:25:26:277:336:684:121:g_d0_f4:121:g_d0_f2:C:REFERENCES 
18:652:57292:26:13:71:517:658:121:g_d0_f3:121:g_d0_f2:B:Antos, Joseph R., "The Wyden–Ryan Proposal — A Foundation for Realistic Medicare Reform," New 
18:653:57386:13:14:108:340:645:121:g_d0_f3:121:g_d0_f2:A:England Journal of Medicine, 2012, 366(10):879‐81. 
18:654:57437:14:13:71:523:631:121:g_d0_f3:121:g_d0_f2:B:Breyer, Friedrich, M. Kate Bundorf, and Mark V. Pauly, "Health Care Spending Risk, Health Insurance, 
18:655:57538:13:14:107:508:618:121:g_d0_f3:121:g_d0_f2:A:and Payment to Health Plans," Handbook of Health Economics, Mark V. Pauly, Thomas G. 
18:656:57623:14:13:107:476:604:121:g_d0_f3:121:g_d0_f2:A:McGuire and Pedro Pita Barros, Eds. Amsterdam, North‐Holland. 2:2012, 691‐762. 
18:657:57702:13:13:71:533:591:121:g_d0_f3:121:g_d0_f2:B:Bronskill, Susan E., Sharon‐Lise T. Normand, Mary Beth Landrum, et al., "Longitudinal Profiles of Health 
18:658:57807:13:14:107:378:578:121:g_d0_f3:121:g_d0_f2:A:Care Providers," Statistics in Medicine, 2002, 21(8):1067‐88. 
18:659:57869:14:13:71:485:564:121:g_d0_f3:121:g_d0_f2:B:Brown, Jason, Mark Duggan, Ilyana Kuziemko, et al., How Does Risk Selection Respnd to Risk 
18:660:57960:13:14:107:540:551:121:g_d0_f3:121:g_d0_f2:A:Adjustment? Evidence from the Medicare Advantage Program. Cambridge, MA, National Bureau 
18:661:58049:14:13:107:236:537:121:g_d0_f3:121:g_d0_f2:A:of Economic Research:2011. 
18:662:58076:13:14:71:528:524:121:g_d0_f3:121:g_d0_f2:B:Cao, Zhun, and Thomas G. McGuire, "Service‐Level Selection by HMOs in Medicare," Journal of Health 
18:663:58175:14:13:108:250:510:121:g_d0_f3:121:g_d0_f2:A:Economics, 2003, 22(6):915‐31. 
18:664:58206:13:13:71:510:497:121:g_d0_f3:121:g_d0_f2:B:Centers for Medicare and Medicaid Services. (2014). "Monthly Contract and Enrollment Summary 
18:665:58299:13:14:107:527:484:121:g_d0_f3:121:g_d0_f2:A:Report."   Retrieved March 19, 2014, from http://www.cms.gov/Research‐Statistics‐Data‐and‐
18:666:58389:14:13:108:500:470:121:g_d0_f3:121:g_d0_f2:A:Systems/Statistics‐Trends‐and‐Reports/MCRAdvPartDEnrolData/Monthly‐Contract‐and‐
18:667:58469:13:14:108:475:457:121:g_d0_f3:121:g_d0_f2:A:Enrollment‐Summary‐Report.html?DLSort=1&DLPage=1&DLSortDir=descending#. 
18:668:58541:14:13:71:525:443:121:g_d0_f3:121:g_d0_f2:B:Congressional Budget Office, "Predicting How Changes in Medicare Payment Rates Would Affect Risk‐
18:669:58638:13:13:107:476:430:121:g_d0_f3:121:g_d0_f2:A:Sector Enrollment and Costs." Washington, DC, Congressional Budget Office:1997. 
18:670:58718:13:14:71:529:417:121:g_d0_f3:121:g_d0_f2:B:Cutler, David M., and Sarah J. Reber, "Paying for Health Insurance: The Tradeoff Between Competition 
18:671:58819:14:13:107:456:403:121:g_d0_f3:121:g_d0_f2:A:and Adverse Selection," Quarterly Journal of Economics, 1998, 113(2):433‐66. 
18:672:58896:13:14:71:525:390:121:g_d0_f3:121:g_d0_f2:B:Cutler, David M., and Richard J. Zeckhauser, "The Anatomy of Health Insurance," Handbook of Health 
18:673:58995:14:13:108:519:376:121:g_d0_f3:121:g_d0_f5:A:Economics, Anthony J.  Culyer and Joseph P. Newhouse, Eds. Amsterdam, Elsevier. 1A:2000, 
18:674:59084:13:14:107:149:363:121:g_d0_f3:121:g_d0_f2:A:563‐644. 
18:675:59093:14:13:71:506:349:121:g_d0_f3:121:g_d0_f2:B:Dubey, Pradeep, and John Geanakoplos, "Competitive Pooling: Rothschild‐Stiglitz Reconsidered," 
18:676:59188:13:14:107:353:336:121:g_d0_f3:121:g_d0_f2:A:Quarterly Journal of Economics, 2002, 117(4):1529‐70. 
18:677:59242:14:13:72:532:322:121:g_d0_f3:121:g_d0_f2:B:Einav, Liran, and Amy N. Finkelstein, "Selection in Insurance Markets: Theory and Empirics in Pictures," 
18:678:59347:13:13:107:351:309:121:g_d0_f3:121:g_d0_f2:A:Journal of Economic Perspectives, 2011, 25(1):115‐38. 
18:679:59401:13:14:71:510:296:121:g_d0_f3:121:g_d0_f2:B:Einav, Liran, Amy N. Finkelstein, and Mark Cullen, "Estimating Welfare in Insurance Markets Using 
18:680:59499:14:13:107:444:282:121:g_d0_f3:121:g_d0_f2:A:Variation in Prices," Quarterly Journal of Economics, 2010, 125(3):877‐921. 
18:681:59575:13:14:72:524:269:121:g_d0_f3:121:g_d0_f2:B:Feldman, Roger, and Bryan Dowd, "Simulation of a Health Insurance Market with Adverse Selection," 
18:682:59673:14:13:107:301:255:121:g_d0_f3:121:g_d0_f2:A:Operations Research, 1982, 30(6):1027‐42. 
18:683:59715:13:14:71:519:242:121:g_d0_f3:121:g_d0_f2:B:Frank, Richard G., Jacob Glazer, and Thomas G. McGuire, "Measuring Adverse Selection in Managed 
18:684:59811:14:13:107:391:228:121:g_d0_f3:121:g_d0_f2:A:Health Care," Journal of Health Economics, 2000, 19(6):829‐54. 
18:685:59874:13:13:71:513:215:121:g_d0_f3:121:g_d0_f2:B:Glied, Sherry A., "Managed Care," Handbook of Health Economics, Anthony J. Culyer and Joseph P. 
18:686:59970:13:14:107:386:202:121:g_d0_f3:121:g_d0_f2:A:Newhouse, Eds. Amsterdam, North‐Holland. 1A:2000, 707‐53. 
18:687:60028:14:13:71:520:188:121:g_d0_f3:121:g_d0_f2:B:Hendren, Nathaniel, "Private Information and Insurance Rejections." Cambridge, National Bureau of 
18:688:60126:13:14:107:224:175:121:g_d0_f3:121:g_d0_f2:A:Economic Research:2012. 
18:689:60150:14:13:71:502:161:121:g_d0_f3:121:g_d0_f2:B:Hofer, Timothy P., Rodney A. Hayward, Sheldon Greenfield, et al., "The Unreliabilty of Individual 
18:690:60248:13:13:107:540:148:121:g_d0_f3:121:g_d0_f2:A:Physician 'Report Cards' for Assessing the Costs and Quality of Care of a Chronic Disease," JAMA, 
18:691:60346:13:14:108:220:135:121:g_d0_f3:121:g_d0_f2:A:1999, 281(24):2098‐105. 
18:692:60370:14:13:72:503:121:121:g_d0_f3:121:g_d0_f2:B:McGuire, Thomas G., Jacob Glazer, Joseph P. Newhouse, et al., "Integrating Risk Adjustment and 
18:693:60465:13:14:107:538:108:121:g_d0_f3:121:g_d0_f2:A:Enrollee Premiums  in Health Plan Payment," Journal of Health Economics, 2013, 32(6):1263‐77. 
18:694:60559:14:13:71:519:94:121:g_d0_f3:121:g_d0_f2:B:McGuire, Thomas G., Joseph P. Newhouse, and Anna D. Sinaiko, "A History of Medicare Part C," The 
18:695:60656:13:0:108:290:81:121:g_d0_f3:121:g_d0_f2:A:Milbank Quarterly, 2011, 89(2):289‐332. 
19:696:60696:0:13:72:504:709:121:g_d0_f3:121:g_d0_f2:B:McWilliams, J. Michael, Christopher C. Afendulis, Thomas G. McGuire, et al., "Complex Medicare 
19:697:60791:13:14:107:539:696:121:g_d0_f3:121:g_d0_f2:A:Advantage Choices May Overwhelm Seniors—Especially Those With Impaired Decision Making," 
19:698:60880:14:13:107:269:682:121:g_d0_f3:121:g_d0_f2:A:Health Affairs, 2011, 30(9):1786‐94. 
19:699:60917:13:14:72:500:669:121:g_d0_f3:121:g_d0_f2:B:McWilliams, J. Michael, John Hsu, and Joseph P. Newhouse, "New Risk‐Adjustment System Was 
19:700:61007:14:13:107:520:655:121:g_d0_f3:121:g_d0_f2:A:Associated With Reduced Favorable Selection In Medicare Advantage," Health Affairs, 2012, 
19:701:61097:13:14:107:181:642:121:g_d0_f3:121:g_d0_f2:A:31(12):2630‐40. 
19:702:61113:14:13:72:505:628:121:g_d0_f3:121:g_d0_f2:B:Medicare Payment Advisory Commission, "Report to the Congress: Improving Risk Adjustment in 
19:703:61205:13:13:107:449:615:121:g_d0_f3:121:g_d0_f2:A:Medicare." Washington, DC, Medicare Payment Advisory Commission:2000. 
19:704:61275:13:14:71:494:602:121:g_d0_f3:121:g_d0_f2:B:Medicare Payment Advisory Commission, "Report to the Congress: Medicare Payment Policy." 
19:705:61364:14:13:107:397:588:121:g_d0_f3:121:g_d0_f2:A:Washington, DC, Medicare Payment Advisory Commission:2007. 
19:706:61423:13:14:71:521:575:121:g_d0_f3:121:g_d0_f2:B:Medicare Payment Advisory Commission, "Report to the Congress: Medicare Payment Policy, March 
19:707:61517:14:13:107:429:561:121:g_d0_f3:121:g_d0_f2:A:2007." Washington, DC, Medicare Payment Advisory Commission:2007. 
19:708:61583:13:13:71:500:548:121:g_d0_f3:121:g_d0_f2:B:Medicare Payment Advisory Commission, "A Data Book: Healthcare Spending and the Medicare 
19:709:61672:13:14:107:445:535:121:g_d0_f3:121:g_d0_f2:A:Program." Washington, DC, Medicare Payment Advisory Commission:2013. 
19:710:61741:14:13:71:535:521:121:g_d0_f3:121:g_d0_f2:B:Morgan, Robert O., Beth A. Virnig, Carolee A. DeVito, et al., "The Medicare‐HMO Revolving Door — The 
19:711:61842:13:14:107:519:508:121:g_d0_f3:121:g_d0_f2:A:Healthy Go in and the Sick Go Out," New England Journal of Medicine, 1997, 337(3):169‐75. 
19:712:61932:14:13:71:521:494:121:g_d0_f3:121:g_d0_f2:B:Newhouse, Joseph P., "Reimbursing Health Plans and Health Providers: Selection versus Efficiency in 
19:713:62032:13:14:107:404:481:121:g_d0_f3:121:g_d0_f2:A:Production," Journal of Economic Literature, 1996, 34(3):1236‐63. 
19:714:62098:14:13:71:517:467:121:g_d0_f3:121:g_d0_f2:B:Newhouse, Joseph P., Pricing the Priceless: A Health Care Conundrum. Cambridge, MIT Press, 2002. 
19:715:62195:13:13:71:501:454:121:g_d0_f3:121:g_d0_f2:B:Newhouse, Joseph P., Jie Huang, Mary Price, et al., "Steps To Reduce Favorable Risk Selection In 
19:716:62292:13:14:107:530:441:121:g_d0_f3:121:g_d0_f2:A:Medicare Advantage Largely Succeeded, Boding Well For Health Insurance Exchanges," Health 
19:717:62382:14:13:108:243:427:121:g_d0_f3:121:g_d0_f2:A:Affairs, 2012, 31(12):2618‐28. 
19:718:62413:13:14:71:534:414:121:g_d0_f3:121:g_d0_f2:B:Newhouse, Joseph P., and Thomas G. McGuire, "How Successful Is Medicare Advantage?," The Milbank 
19:719:62510:14:13:108:249:400:121:g_d0_f3:121:g_d0_f2:A:Quarterly, 2014, 92(2):in press. 
19:720:62543:13:14:71:526:387:121:g_d0_f3:121:g_d0_f2:B:Newhouse, Joseph P., J. Michael McWilliams, Mary Price, et al., "How Much Do Health Plans Select?," 
19:721:62643:14:13:107:335:373:121:g_d0_f3:121:g_d0_f2:A:Journal of Health Economics, 2013, 32(6):1278‐88. 
19:722:62693:13:13:71:501:360:121:g_d0_f3:121:g_d0_f2:B:Newhouse, Joseph P., Mary Price, Jie Huang, et al., "Steps To Reduce Favorable Risk Selection In 
19:723:62790:13:14:107:530:347:121:g_d0_f3:121:g_d0_f2:A:Medicare Advantage Largely Succeeded, Boding Well For Health Insurance Exchanges," Health 
19:724:62880:14:13:108:243:333:121:g_d0_f3:121:g_d0_f2:A:Affairs, 2012, 31(12):2618‐28. 
19:725:62911:13:14:71:525:320:121:g_d0_f3:121:g_d0_f2:B:Physician Payment Review Commission, Annual Report to Congress, 1996. Washington, DC, Physician 
19:726:63007:14:13:107:271:306:121:g_d0_f3:121:g_d0_f2:A:Payment Review Commission, 1996. 
19:727:63040:13:14:71:541:293:121:g_d0_f3:121:g_d0_f2:B:Pope, Gregory C., John Kautter, Randall P. Ellis, et al., "Risk Adjustment of Medicare Capitation Payments 
19:728:63147:14:13:107:463:279:121:g_d0_f3:121:g_d0_f2:A:Using the CMS‐HCC Model," Health Care Financing Review, 2004, 25(4):119‐41. 
19:729:63223:13:13:71:540:266:121:g_d0_f3:121:g_d0_f2:B:Prospective Payment Assessment Commission, "Medicare and the American Health Care System: Report 
19:730:63320:13:14:107:466:253:121:g_d0_f3:121:g_d0_f2:A:to the Congress, June 1997." Washington, DC, Prospective Payment Assessment 
19:731:63396:14:13:107:192:239:121:g_d0_f3:121:g_d0_f2:A:Commission:1997. 
19:732:63413:13:14:71:538:226:121:g_d0_f3:121:g_d0_f2:B:Rothschild, Michael, and Joseph Stiglitz, "Equilibrium in Competitive Insurance Markets: An Essay on the 
19:733:63518:14:13:107:513:212:121:g_d0_f3:121:g_d0_f2:A:Economics of Imperfect Information," Quarterly Journal of Economics, 1976, 90(4):629‐50. 
19:734:63607:13:14:72:541:199:121:g_d0_f3:121:g_d0_f2:B:Samuelson, William, and Richard J. Zeckhauser, "Status Quo Bias in Decision Making," Journal of Risk and 
19:735:63712:14:13:108:229:185:121:g_d0_f3:121:g_d0_f2:A:Insurance, 1988, 1(1):7‐59. 
19:736:63740:13:13:71:532:172:121:g_d0_f3:121:g_d0_f2:B:Shore, Karen K., and John Bertko (1999), "Comparison of Small Group Rates in California:  HIPC vs. Non‐
19:737:63843:13:14:107:286:159:121:g_d0_f3:121:g_d0_f2:A:HIPC,"  Retrieved March 17, 2014, from 
19:738:63882:14:13:107:509:145:121:g_d0_f3:121:g_d0_f2:A:http://www.chcf.org/~/media/MEDIA%20LIBRARY%20Files/PDF/H/PDF%20hipcrates.pdf. 
19:739:63961:13:14:71:507:132:121:g_d0_f3:121:g_d0_f2:B:Weinberg, Micah, and Bill Kramer (2011), "Building Successful SHOP Exchanges: Lessons from the 
19:740:64056:14:13:107:359:118:121:g_d0_f3:121:g_d0_f2:A:California Experience,"  Retrieved March 17, 2014, from 
19:741:64112:13:14:107:396:105:121:g_d0_f3:121:g_d0_f2:A:http://www.pbgh.org/storage/documents/PBGH_SHOP_05.pdf. 
19:742:64168:14:13:72:530:91:121:g_d0_f3:121:g_d0_f2:B:Wilson, Charles A., "A Model of Insurance Markets with Incomplete Information," Journal of Economic 
19:743:64268:13:0:108:239:78:121:g_d0_f3:121:g_d0_f2:A:Theory, 1977, 16(2):167‐207. 
20:744:64297:0:13:72:509:709:121:g_d0_f3:121:g_d0_f2:B:Yegian, Jill Mathews, Thomas C. Buchmueller, Mark D. Smith, et al., "The Health Insurance Plan of 
20:745:64395:13:24:107:407:696:121:g_d0_f3:121:g_d0_f2:A:California: The First Five Years," Health Affairs, 2000, 19(5):158‐65. 
20:746:64466:24:23:71:73:672:121:g_d0_f2:121:g_d0_f2:B: 
20:747:64467:23:24:71:73:649:121:g_d0_f2:121:g_d0_f2:B: 
20:748:64468:24:0:71:359:625:121:g_d0_f2:121:g_d0_f2:B:  
21:749:64470:0:25:72:74:709:121:g_d0_f2:121:g_d0_f2:B: 
21:750:64471:25:25:145:458:684:121:g_d0_f3:121:g_d0_f2:A:Table 1: Beneficiaries by Age and Original Reason for Eligibility (ORE)* 
21:751:64544:25:24:113:541:659:100:Helvetica:100:Helvetica:?:                                                                              ORE=Aged                                       ORE=Disability                                       or                                       ESRD                                       
21:752:64806:24:24:183:472:635:100:Helvetica:100:Helvetica:?: Total Age 65+ Age 65+ Age <65 
21:753:64836:24:23:122:522:611:100:Helvetica:100:Helvetica:F:2001           5,760,821           4,563,388           79.2%           422,207           7.3%           775,226           13.5%           
21:754:64974:23:23:122:522:588:100:Helvetica:100:Helvetica:F:2002           5,959,061           4,701,352           78.9%           442,511           7.4%           815,198           13.7%           
21:755:65112:23:23:122:522:565:100:Helvetica:100:Helvetica:F:2003           6,095,807           4,779,197           78.4%           458,698           7.5%           857,912           14.1%           
21:756:65250:23:23:122:522:542:100:Helvetica:100:Helvetica:F:2004           6,143,162           4,781,953           77.8%           465,479           7.6%           895,730           14.6%           
21:757:65388:23:24:122:522:519:100:Helvetica:100:Helvetica:F:2005           6,129,633           4,740,059           77.3%           467,811           7.6%           921,763           15.0%           
21:758:65526:24:23:122:522:495:100:Helvetica:100:Helvetica:F:2006           5,974,412           4,607,287           77.1%           459,927           7.7%           907,198           15.2%           
21:759:65664:23:23:122:522:472:100:Helvetica:100:Helvetica:F:2007           5,887,761           4,506,823           76.5%           460,829           7.8%           920,109           15.6%           
21:760:65802:23:23:122:522:449:100:Helvetica:100:Helvetica:F:2008           5,820,956           4,427,286           76.1%           465,482           8.0%           928,188           15.9%           
21:761:65940:23:23:122:522:426:100:Helvetica:100:Helvetica:F:2009           5,871,707           4,429,056           75.4%           476,663           8.1%           965,988           16.5%           
21:762:66078:23:25:122:522:403:100:Helvetica:100:Helvetica:F:2010           5,958,291           4,462,672           74.9%           498,891           8.4%           996,728           16.7%           
21:763:66216:25:16:63:541:378:121:g_d0_f3:121:g_d0_f2:C:*The following types of beneficiaries were excluded from the sample: newly eligible beneficiaries (since no 
21:764:66324:16:15:62:495:362:121:g_d0_f3:121:g_d0_f2:C:prior claims information was available); beneficiaries who did not have 12 months of continuous 
21:765:66420:15:16:62:531:347:121:g_d0_f3:121:g_d0_f2:C:enrollment in TM, both Parts A and B, in the prior year.  In addition, beneficiaries who switched into cost 
21:766:66528:16:25:62:283:331:121:g_d0_f3:121:g_d0_f2:C:MA plans or special needs plans were excluded.   
21:767:66577:25:15:71:73:306:121:g_d0_f2:121:g_d0_f2:B: 
21:768:66578:15:26:71:73:291:121:g_d0_f2:121:g_d0_f2:B: 
21:769:66579:26:0:71:359:265:121:g_d0_f2:121:g_d0_f2:B:  
22:770:66581:0:25:72:74:709:121:g_d0_f2:121:g_d0_f2:B: 
22:771:66582:25:26:160:453:684:121:g_d0_f3:121:g_d0_f2:C:Table 2a:  Unadjusted expenditures by Year and Switching Status, 
22:772:66647:26:25:230:383:658:121:g_d0_f3:121:g_d0_f2:C:Non‐Institutionalized, Non‐Duals* 
22:773:66681:25:23:182:490:633:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to MA in Next Year 
22:774:66731:23:26:165:546:610:100:Helvetica:100:Helvetica:?:                N                Mean                $                SD                N                Mean                $                SD                
22:775:66891:26:26:77:521:584:100:Helvetica:121:g_d0_f3:F:2001 3,731,431 5,32511,14424,5623,739 8,711
22:776:66934:26:25:77:521:558:100:Helvetica:121:g_d0_f3:F:2002 3,851,378 6,00113,03426,1294,006 9,628
22:777:66977:25:26:77:521:533:100:Helvetica:121:g_d0_f3:F:2003 3,971,622 6,35813,43341,7984,183 9,416
22:778:67020:26:25:77:521:507:100:Helvetica:121:g_d0_f3:F:2004 3,927,310 6,65113,83777,1934,566 10,060
22:779:67064:25:25:77:521:482:100:Helvetica:121:g_d0_f3:F:2005 3,789,618 6,87114,169160,2304,722 10,210
22:780:67109:25:26:77:521:457:100:Helvetica:121:g_d0_f3:F:2006 3,687,693 6,95814,406161,7535,750 11,947
22:781:67154:26:25:77:521:431:100:Helvetica:121:g_d0_f3:F:2007 3,610,107 7,01614,527156,7275,822 12,222
22:782:67199:25:26:77:521:406:100:Helvetica:121:g_d0_f3:F:2008 3,531,134 7,01514,670126,8555,374 11,752
22:783:67244:26:25:77:521:380:100:Helvetica:121:g_d0_f3:F:2009 3,537,119 7,26315,349111,6165,776 12,908
22:784:67289:25:25:77:521:355:100:Helvetica:121:g_d0_f3:F:2010 3,577,950 7,34315,51091,6205,590 12,256
22:785:67333:25:16:72:506:330:121:g_d0_f3:121:g_d0_f2:B:*2007$ The following types of beneficiaries were excluded from the sample: Beneficiaries whose 
22:786:67428:16:15:71:541:314:121:g_d0_f3:121:g_d0_f2:B:original eligibility was attributable to disability or ESRD; newly eligible beneficiaries (since no prior claims 
22:787:67541:15:15:71:532:299:121:g_d0_f3:121:g_d0_f2:B:information was available); beneficiaries who did not have 12 months of continuous enrollment in TM, 
22:788:67642:15:16:71:529:284:121:g_d0_f3:121:g_d0_f2:B:both Parts A and B, in the prior year; the institutionalized; and dual eligibles.  In addition, beneficiaries 
22:789:67752:16:25:71:397:268:121:g_d0_f3:121:g_d0_f2:B:who switched into cost MA plans or special needs plans were excluded.   
22:790:67824:25:26:71:73:243:121:g_d0_f2:121:g_d0_f2:B: 
22:791:67825:26:25:71:73:217:121:g_d0_f2:121:g_d0_f2:B: 
22:792:67826:25:26:71:73:192:121:g_d0_f2:121:g_d0_f2:B: 
22:793:67827:26:25:71:73:166:121:g_d0_f2:121:g_d0_f2:B: 
22:794:67828:25:26:71:73:141:121:g_d0_f2:121:g_d0_f2:B: 
22:795:67829:26:25:71:73:115:121:g_d0_f2:121:g_d0_f2:B: 
22:796:67830:25:0:71:73:90:121:g_d0_f2:121:g_d0_f2:B: 
23:797:67831:0:25:163:450:709:121:g_d0_f3:121:g_d0_f2:C:Table 2b:  Unadjusted Risk Scores* by Year and Switching Status 
23:798:67895:25:25:232:381:684:121:g_d0_f3:121:g_d0_f2:C:Non‐Institutionalized, Non‐Duals 
23:799:67928:25:24:182:490:659:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to MA in Next Year 
23:800:67978:24:26:189:521:635:100:Helvetica:100:Helvetica:F: N    Mean ScoreSDNMean Score SD
23:801:68009:26:25:77:521:609:100:Helvetica:121:g_d0_f3:F:2001 3,731,431 0.9220.76024,5620.788 0.658
23:802:68051:25:26:77:521:584:100:Helvetica:121:g_d0_f3:F:2002 3,851,378 0.9530.81726,1290.804 0.687
23:803:68093:26:25:77:521:558:100:Helvetica:121:g_d0_f3:F:2003 3,971,622 0.9760.84441,7980.809 0.686
23:804:68135:25:26:77:521:533:100:Helvetica:121:g_d0_f3:F:2004 3,927,310 0.9830.85277,1930.842 0.714
23:805:68177:26:25:77:521:507:100:Helvetica:121:g_d0_f3:F:2005 3,789,618 1.0000.868160,2300.853 0.716
23:806:68220:25:25:77:521:482:100:Helvetica:121:g_d0_f3:F:2006 3,687,693 1.0180.886161,7530.927 0.800
23:807:68263:25:26:77:521:457:100:Helvetica:121:g_d0_f3:F:2007 3,610,107 1.0230.881156,7270.947 0.813
23:808:68306:26:25:77:521:431:100:Helvetica:121:g_d0_f3:F:2008 3,531,134 1.0040.829126,8550.883 0.730
23:809:68349:25:26:77:521:406:100:Helvetica:121:g_d0_f3:F:2009 3,537,119 1.0100.838111,6160.898 0.753
23:810:68392:26:25:77:521:380:100:Helvetica:121:g_d0_f3:F:2010 3,577,950 0.9670.79991,6200.846 0.708
23:811:68434:25:25:72:345:355:121:g_d0_f3:121:g_d0_f2:B:*Risk scores are computed using the 2007 CMS‐HCC model.   
23:812:68492:25:26:71:73:330:121:g_d0_f2:121:g_d0_f2:B: 
23:813:68493:26:25:71:73:304:121:g_d0_f2:121:g_d0_f2:B: 
23:814:68494:25:25:71:73:279:121:g_d0_f2:121:g_d0_f2:B: 
23:815:68495:25:26:71:73:254:121:g_d0_f2:121:g_d0_f2:B: 
23:816:68496:26:25:71:73:228:121:g_d0_f2:121:g_d0_f2:B: 
23:817:68497:25:26:71:73:203:121:g_d0_f2:121:g_d0_f2:B: 
23:818:68498:26:25:71:73:177:121:g_d0_f2:121:g_d0_f2:B: 
23:819:68499:25:26:71:73:152:121:g_d0_f2:121:g_d0_f2:B: 
23:820:68500:26:25:71:73:126:121:g_d0_f2:121:g_d0_f2:B: 
23:821:68501:25:26:71:73:101:121:g_d0_f2:121:g_d0_f2:B: 
23:822:68502:26:0:283:285:75:121:g_d0_f2:121:g_d0_f2:C: 
24:823:68503:0:25:138:430:709:121:g_d0_f3:121:g_d0_f2:C:Table 3a:  Unadjusted expenditures by Year and Switching Status 
24:824:68567:25:25:222:346:684:121:g_d0_f3:121:g_d0_f2:C:Non‐institutionalized Duals 
24:825:68595:25:24:177:488:659:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to HMO in Next Year 
24:826:68646:24:26:72:516:635:100:Helvetica:100:Helvetica:F:                                        N                                        MeanSDNMean                                        SD
24:827:68780:26:25:72:518:609:100:Helvetica:121:g_d0_f2:B:2001  380,492      7,277  14,437  2,732  6,925     14,772 
24:828:68838:25:26:72:518:584:100:Helvetica:121:g_d0_f2:B:2002  395,135      8,376  16,866  3,023  7,881     15,810 
24:829:68896:26:25:72:518:558:100:Helvetica:121:g_d0_f2:B:2003  412,942      8,969  17,326  5,216  7,653     16,084 
24:830:68954:25:26:72:518:533:100:Helvetica:121:g_d0_f2:B:2004  404,749      9,214  17,675  12,546  8,225     16,357 
24:831:69013:26:25:72:518:507:100:Helvetica:121:g_d0_f2:B:2005  389,618      9,574  18,379  39,323  7,973     15,659 
24:832:69072:25:25:72:518:482:100:Helvetica:121:g_d0_f2:B:2006  375,952      9,756  18,745  28,342  8,885     16,522 
24:833:69131:25:26:72:518:457:100:Helvetica:121:g_d0_f2:B:2007  367,100      9,953  19,349  23,563  8,722     16,203 
24:834:69190:26:25:72:518:431:100:Helvetica:121:g_d0_f2:B:2008  408,096     10,357  19,788  20,555  8,865     17,365 
24:835:69249:25:26:72:518:406:100:Helvetica:121:g_d0_f2:B:2009  419,309     10,803  20,709  18,297  9,527     17,780 
24:836:69308:26:25:72:518:380:100:Helvetica:121:g_d0_f2:B:2010  427,833     10,665  20,520  18,567  9,052     17,715 
24:837:69367:25:15:72:519:355:121:g_d0_f3:121:g_d0_f2:B:*in 2007$  The following types of beneficiaries were excluded from the sample: Beneficiaries whose 
24:838:69466:15:16:71:532:340:121:g_d0_f3:121:g_d0_f2:B:original eligibility was attributable to disability ,ESRD, or Alzheimer’s; newly eligible beneficiaries (since 
24:839:69577:16:15:71:518:324:121:g_d0_f3:121:g_d0_f2:B:no prior claims information was available); beneficiaries who did not have 12 months of continuous 
24:840:69676:15:15:71:511:309:121:g_d0_f3:121:g_d0_f2:B:enrollment in TM, both Parts A and B, in the prior year; the institutionalized; and dual eligibles.  In 
24:841:69780:15:26:71:499:294:121:g_d0_f3:121:g_d0_f2:B:addition, beneficiaries who switched into cost MA plans or special needs plans were excluded.   
24:842:69876:26:25:71:73:268:121:g_d0_f2:121:g_d0_f2:B: 
24:843:69877:25:26:71:73:243:121:g_d0_f2:121:g_d0_f2:B: 
24:844:69878:26:25:71:73:217:121:g_d0_f2:121:g_d0_f2:B: 
24:845:69879:25:26:71:73:192:121:g_d0_f2:121:g_d0_f2:B: 
24:846:69880:26:25:71:73:166:121:g_d0_f2:121:g_d0_f2:B: 
24:847:69881:25:26:71:73:141:121:g_d0_f2:121:g_d0_f2:B: 
24:848:69882:26:25:71:73:115:121:g_d0_f2:121:g_d0_f2:B: 
24:849:69883:25:0:71:73:90:121:g_d0_f2:121:g_d0_f2:B: 
25:850:69884:0:25:140:428:709:121:g_d0_f3:121:g_d0_f2:A:Table 3b:  Unadjusted Risk Scores* by Year and Switching Status 
25:851:69948:25:25:222:346:684:121:g_d0_f3:121:g_d0_f2:C:Non‐institutionalized Duals 
25:852:69976:25:24:177:488:659:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to HMO in Next Year 
25:853:70027:24:26:72:516:635:100:Helvetica:100:Helvetica:F:                                        N                                        MeanSDNMean                                        SD
25:854:70161:26:25:72:516:609:100:Helvetica:121:g_d0_f3:C:2001  380,492  1.28010.9305 2,732 1.184 0.848
25:855:70206:25:26:72:516:584:100:Helvetica:121:g_d0_f3:C:2002  395,135  1.33620.9960 3,023 1.211 0.897
25:856:70251:26:25:72:516:558:100:Helvetica:121:g_d0_f3:C:2003  412,942  1.37311.0317 5,216 1.191 0.926
25:857:70296:25:26:72:516:533:100:Helvetica:121:g_d0_f3:C:2004  404,749  1.37721.0385 12,546 1.253 0.931
25:858:70342:26:25:72:516:507:100:Helvetica:121:g_d0_f3:C:2005  389,618  1.39791.0533 39,323 1.277 0.938
25:859:70388:25:25:72:516:482:100:Helvetica:121:g_d0_f3:C:2006  375,952  1.42431.0818 28,342 1.342 0.989
25:860:70434:25:26:72:516:457:100:Helvetica:121:g_d0_f3:C:2007  367,100  1.43361.0814 23,563 1.322 0.981
25:861:70480:26:25:72:516:431:100:Helvetica:121:g_d0_f3:C:2008  408,096  1.40991.0215 20,555 1.284 0.922
25:862:70526:25:26:72:516:406:100:Helvetica:121:g_d0_f3:C:2009  419,309  1.44031.0304 18,297 1.299 0.943
25:863:70572:26:25:72:516:380:100:Helvetica:121:g_d0_f3:C:2010  427,833  1.36920.9835 18,567 1.228 0.888
25:864:70618:25:25:72:347:355:121:g_d0_f3:121:g_d0_f2:B:* Risk scores are computed using the 2007 CMS‐HCC model.   
25:865:70677:25:26:71:73:330:121:g_d0_f2:121:g_d0_f2:B: 
25:866:70678:26:25:26:28:304:121:g_d0_f2:121:g_d0_f2:C: 
25:867:70679:25:0:71:359:279:121:g_d0_f2:121:g_d0_f2:B:  
26:868:70681:0:25:136:432:709:121:g_d0_f3:121:g_d0_f2:C:Table 4a:  Unadjusted expenditures* by Year and Switching Status 
26:869:70746:25:25:247:321:684:121:g_d0_f3:121:g_d0_f2:C:Institutionalized 
26:870:70764:25:24:177:489:659:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to HMO in Next Year 
26:871:70815:24:26:72:516:635:100:Helvetica:100:Helvetica:F:                                        N                                        MeanSDNMean                                        SD
26:872:70949:26:25:72:517:609:100:Helvetica:121:g_d0_f3:F:2001 421,423 21,86030,1612,74823,305 28,939
26:873:70992:25:26:72:517:584:100:Helvetica:121:g_d0_f3:F:2002 423,218 17,89927,2762,46920,997 28,985
26:874:71035:26:25:72:517:558:100:Helvetica:121:g_d0_f3:F:2003 345,235 19,14428,2502,38420,662 30,462
26:875:71078:25:26:72:517:533:100:Helvetica:121:g_d0_f3:F:2004 356,336 19,94929,0523,81921,077 30,964
26:876:71121:26:25:72:517:507:100:Helvetica:121:g_d0_f3:F:2005 351,318 20,73829,8469,95218,285 27,269
26:877:71164:25:25:72:517:482:100:Helvetica:121:g_d0_f3:F:2006 345,477 20,99630,4218,07020,755 30,130
26:878:71207:25:26:72:517:457:100:Helvetica:121:g_d0_f3:F:2007 340,690 21,49130,9188,63620,910 29,790
26:879:71250:26:25:72:517:431:100:Helvetica:121:g_d0_f3:F:2008 334,485 22,26431,5606,16120,742 28,957
26:880:71293:25:26:72:517:406:100:Helvetica:121:g_d0_f3:F:2009 336,523 23,39333,2896,19223,283 32,872
26:881:71336:26:25:72:517:380:100:Helvetica:121:g_d0_f3:F:2010 341,551 23,56033,6005,15123,015 32,490
26:882:71379:25:15:72:511:355:121:g_d0_f3:121:g_d0_f2:B:*2007$.  The following types of beneficiaries were excluded from the sample: Beneficiaries whose 
26:883:71476:15:16:71:532:340:121:g_d0_f3:121:g_d0_f2:B:original eligibility was attributable to disability ,ESRD, or Alzheimer’s; newly eligible beneficiaries (since 
26:884:71587:16:15:71:518:324:121:g_d0_f3:121:g_d0_f2:B:no prior claims information was available); beneficiaries who did not have 12 months of continuous 
26:885:71686:15:15:71:540:309:121:g_d0_f3:121:g_d0_f2:B:enrollment in TM, both Parts A and B, in the prior year.  In addition, beneficiaries who switched into cost 
26:886:71794:15:26:71:292:294:121:g_d0_f3:121:g_d0_f2:B:MA plans or special needs plans were excluded.   
26:887:71843:26:25:111:113:268:121:g_d0_f2:121:g_d0_f2:C: 
26:888:71844:25:26:111:113:243:121:g_d0_f2:121:g_d0_f2:C: 
26:889:71845:26:25:111:113:217:121:g_d0_f2:121:g_d0_f2:C: 
26:890:71846:25:26:111:113:192:121:g_d0_f2:121:g_d0_f2:C: 
26:891:71847:26:25:111:113:166:121:g_d0_f2:121:g_d0_f2:C: 
26:892:71848:25:26:111:113:141:121:g_d0_f2:121:g_d0_f2:C: 
26:893:71849:26:25:111:113:115:121:g_d0_f2:121:g_d0_f2:C: 
26:894:71850:25:0:111:113:90:121:g_d0_f2:121:g_d0_f2:C: 
27:895:71851:0:25:126:486:709:121:g_d0_f3:121:g_d0_f2:C:Table 4b:  Institutionalized: Unadjusted Risk Scores by Year and Switching Status 
27:896:71933:25:25:269:344:684:121:g_d0_f3:121:g_d0_f2:C:Institutionalized 
27:897:71951:25:24:177:488:659:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to HMO in Next Year 
27:898:72002:24:26:72:516:635:100:Helvetica:100:Helvetica:F:                                        N                                        MeanSDNMean                                        SD
27:899:72136:26:25:72:516:609:100:Helvetica:121:g_d0_f3:C:2001  421,423  1.7971.050 2,748 1.815 1.018
27:900:72179:25:26:72:516:584:100:Helvetica:121:g_d0_f3:C:2002  423,218  1.7200.999 2,469 1.780 0.991
27:901:72222:26:25:72:516:558:100:Helvetica:121:g_d0_f3:C:2003  345,235  1.7511.031 2,384 1.731 0.975
27:902:72265:25:26:72:516:533:100:Helvetica:121:g_d0_f3:C:2004  356,336  1.7531.036 3,819 1.747 0.989
27:903:72308:26:25:72:516:507:100:Helvetica:121:g_d0_f3:C:2005  351,318  1.7741.057 9,952 1.717 0.977
27:904:72351:25:25:72:516:482:100:Helvetica:121:g_d0_f3:C:2006  345,477  1.7931.068 8,070 1.800 1.047
27:905:72394:25:26:72:516:457:100:Helvetica:121:g_d0_f3:C:2007  340,690  1.8011.072 8,636 1.786 1.026
27:906:72437:26:25:72:516:431:100:Helvetica:121:g_d0_f3:C:2008  334,485  1.7510.987 6,161 1.717 0.921
27:907:72480:25:26:72:516:406:100:Helvetica:121:g_d0_f3:C:2009  336,523  1.7670.984 6,192 1.768 0.951
27:908:72523:26:25:72:516:380:100:Helvetica:121:g_d0_f3:C:2010  341,551  1.6870.946 5,151 1.702 0.922
27:909:72566:25:25:72:340:355:121:g_d0_f3:121:g_d0_f2:B:Risk scores are computed using the 2007 CMS‐HCC model.   
27:910:72623:25:26:71:73:330:121:g_d0_f2:121:g_d0_f2:B: 
27:911:72624:26:25:26:28:304:121:g_d0_f2:121:g_d0_f2:C: 
27:912:72625:25:25:89:91:279:121:g_d0_f2:121:g_d0_f2:C: 
27:913:72626:25:0:71:359:254:121:g_d0_f2:121:g_d0_f2:B:  
28:914:72628:0:25:283:285:709:121:g_d0_f2:121:g_d0_f2:C: 
28:915:72629:25:26:160:453:684:121:g_d0_f3:121:g_d0_f2:C:Table 5a:  Unadjusted expenditures by Year and Switching Status, 
28:916:72694:26:25:230:383:658:121:g_d0_f3:121:g_d0_f2:C:Non‐Institutionalized, Non‐Duals* 
28:917:72728:25:23:182:507:633:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to MA-HMO’s in Next Year 
28:918:72784:23:26:165:546:610:100:Helvetica:100:Helvetica:?:                N                Mean                $                SD                N                Mean                $                SD                
28:919:72944:26:26:77:523:584:100:Helvetica:121:g_d0_f2:A:2001  3,731,431      5,325  11,144  23,966  3,714      8,691 
28:920:73005:26:25:77:523:558:100:Helvetica:121:g_d0_f2:A:2002  3,851,378      6,001  13,034  24,988  4,033      9,725 
28:921:73066:25:26:77:523:533:100:Helvetica:121:g_d0_f2:A:2003  3,971,622      6,358  13,433  37,727  4,210      9,524 
28:922:73127:26:25:77:523:507:100:Helvetica:121:g_d0_f2:A:2004  3,927,310      6,651  13,837  58,207  4,657     10,288 
28:923:73188:25:25:77:523:482:100:Helvetica:121:g_d0_f2:A:2005  3,789,618      6,871  14,169  87,142  4,766     10,257 
28:924:73249:25:26:77:523:457:100:Helvetica:121:g_d0_f2:A:2006  3,687,693      6,958  14,406  53,373  5,279     11,456 
28:925:73310:26:25:77:523:431:100:Helvetica:121:g_d0_f2:A:2007  3,610,107      7,016  14,527  70,898  5,389     11,705 
28:926:73371:25:26:77:523:406:100:Helvetica:121:g_d0_f2:A:2008  3,531,134      7,015  14,670  74,039  4,940     10,973 
28:927:73432:26:25:77:523:380:100:Helvetica:121:g_d0_f2:A:2009  3,537,119      7,263  15,349  85,114  5,662     12,796 
28:928:73493:25:15:72:506:355:121:g_d0_f3:121:g_d0_f2:B:*2007$ The following types of beneficiaries were excluded from the sample: Beneficiaries whose 
28:929:73588:15:16:71:532:340:121:g_d0_f3:121:g_d0_f2:B:original eligibility was attributable to disability ,ESRD, or Alzheimer’s; newly eligible beneficiaries (since 
28:930:73699:16:15:71:518:324:121:g_d0_f3:121:g_d0_f2:B:no prior claims information was available); beneficiaries who did not have 12 months of continuous 
28:931:73798:15:15:71:511:309:121:g_d0_f3:121:g_d0_f2:B:enrollment in TM, both Parts A and B, in the prior year; the institutionalized; and dual eligibles.  In 
28:932:73902:15:16:71:523:294:121:g_d0_f3:121:g_d0_f2:B:addition, beneficiaries who switched into PFFS, cost MA plans or special needs plans were excluded.  
28:933:74003:16:15:71:512:278:121:g_d0_f3:121:g_d0_f2:B:MA‐PPO enrollees are included.  2010 values are not shown in this table because we are unable to 
28:934:74100:15:26:71:313:263:121:g_d0_f3:121:g_d0_f2:B:identify the type of MA plan that was chosen in 2010. 
28:935:74154:26:25:71:73:237:121:g_d0_f2:121:g_d0_f2:B: 
28:936:74155:25:26:71:73:212:121:g_d0_f2:121:g_d0_f2:B: 
28:937:74156:26:25:71:73:186:121:g_d0_f2:121:g_d0_f2:B: 
28:938:74157:25:26:71:73:161:121:g_d0_f2:121:g_d0_f2:B: 
28:939:74158:26:25:71:73:135:121:g_d0_f2:121:g_d0_f2:B: 
28:940:74159:25:25:71:73:110:121:g_d0_f2:121:g_d0_f2:B: 
28:941:74160:25:0:71:73:85:121:g_d0_f2:121:g_d0_f2:B: 
29:942:74161:0:25:163:450:709:121:g_d0_f3:121:g_d0_f2:C:Table 5b:  Unadjusted Risk Scores* by Year and Switching Status 
29:943:74225:25:25:232:381:684:121:g_d0_f3:121:g_d0_f2:C:Non‐Institutionalized, Non‐Duals 
29:944:74258:25:24:182:507:659:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to MA-HMO’s in Next Year 
29:945:74314:24:26:189:521:635:100:Helvetica:100:Helvetica:F: N    Mean ScoreSDNMean Score SD
29:946:74345:26:25:77:521:609:100:Helvetica:121:g_d0_f3:F:2001  3,731,431  0.9220.760 23,966 0.786 0.658
29:947:74391:25:26:77:521:584:100:Helvetica:121:g_d0_f3:F:2002  3,851,378  0.9530.817 24,988 0.806 0.689
29:948:74437:26:25:77:521:558:100:Helvetica:121:g_d0_f3:F:2003  3,971,622  0.9760.844 37,727 0.817 0.695
29:949:74483:25:26:77:521:533:100:Helvetica:121:g_d0_f3:F:2004  3,927,310  0.9830.852 58,207 0.860 0.737
29:950:74529:26:25:77:521:507:100:Helvetica:121:g_d0_f3:F:2005  3,789,618  1.0000.868 87,142 0.872 0.735
29:951:74575:25:25:77:521:482:100:Helvetica:121:g_d0_f3:F:2006  3,687,693  1.0180.886 53,373 0.897 0.785
29:952:74621:25:26:77:521:457:100:Helvetica:121:g_d0_f3:F:2007  3,610,107  1.0230.881 70,898 0.901 0.779
29:953:74667:26:25:77:521:431:100:Helvetica:121:g_d0_f3:F:2008  3,531,134  1.0040.829 74,039 0.850 0.702
29:954:74713:25:25:77:521:406:100:Helvetica:121:g_d0_f3:F:2009  3,537,119  1.0100.838 85,114 0.891 0.751
29:955:74759:25:26:72:345:381:121:g_d0_f3:121:g_d0_f2:B:*Risk scores are computed using the 2007 CMS‐HCC model.   
29:956:74817:26:0:71:359:355:121:g_d0_f2:121:g_d0_f2:B:  
30:957:74819:0:25:283:285:709:121:g_d0_f2:121:g_d0_f2:C: 
30:958:74820:25:26:160:453:684:121:g_d0_f3:121:g_d0_f2:C:Table 6a:  Unadjusted expenditures by Year and Switching Status, 
30:959:74885:26:25:230:383:658:121:g_d0_f3:121:g_d0_f2:C:Non‐Institutionalized, Non‐Duals* 
30:960:74919:25:23:182:504:633:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to MA-PFFS in Next Year 
30:961:74974:23:26:165:546:610:100:Helvetica:100:Helvetica:?:                N                Mean                $                SD                N                Mean                $                SD                
30:962:75134:26:26:77:523:584:100:Helvetica:121:g_d0_f2:A:2001  3,731,431      5,325  11,144  596  4,764      9,445 
30:963:75192:26:25:77:523:558:100:Helvetica:121:g_d0_f2:A:2002  3,851,378      6,001  13,034  1,141  3,416      7,155 
30:964:75252:25:26:77:523:533:100:Helvetica:121:g_d0_f2:A:2003  3,971,622      6,358  13,433  4,071  3,934      8,345 
30:965:75312:26:25:77:523:507:100:Helvetica:121:g_d0_f2:A:2004  3,927,310      6,651  13,837  18,986  4,286      9,323 
30:966:75373:25:25:77:523:482:100:Helvetica:121:g_d0_f2:A:2005  3,789,618      6,871  14,169  73,088  4,668     10,153 
30:967:75434:25:26:77:523:457:100:Helvetica:121:g_d0_f2:A:2006  3,687,693      6,958  14,406  108,380  5,982     12,175 
30:968:75496:26:25:77:523:431:100:Helvetica:121:g_d0_f2:A:2007  3,610,107      7,016  14,527  85,829  6,180     12,621 
30:969:75557:25:26:77:523:406:100:Helvetica:121:g_d0_f2:A:2008  3,531,134      7,015  14,670  52,816  5,982     12,739 
30:970:75618:26:25:77:523:380:100:Helvetica:121:g_d0_f2:A:2009  3,537,119      7,263  15,349  26,502  6,143     13,253 
30:971:75679:25:15:72:509:355:121:g_d0_f3:121:g_d0_f2:B:*2007$. The following types of beneficiaries were excluded from the sample: Beneficiaries whose 
30:972:75775:15:16:71:532:340:121:g_d0_f3:121:g_d0_f2:B:original eligibility was attributable to disability ,ESRD, or Alzheimer’s; newly eligible beneficiaries (since 
30:973:75886:16:15:71:518:324:121:g_d0_f3:121:g_d0_f2:B:no prior claims information was available); beneficiaries who did not have 12 months of continuous 
30:974:75985:15:15:71:511:309:121:g_d0_f3:121:g_d0_f2:B:enrollment in TM, both Parts A and B, in the prior year; the institutionalized; and dual eligibles.  In 
30:975:76089:15:16:71:521:294:121:g_d0_f3:121:g_d0_f2:B:addition, beneficiaries who switched into cost MA plans or special needs plans were excluded.  2010 
30:976:76189:16:15:71:510:278:121:g_d0_f3:121:g_d0_f2:B:values are not shown in this table because we are unable to identify the type of MA plan that was 
30:977:76287:15:26:71:144:263:121:g_d0_f3:121:g_d0_f2:B:chosen in 2010. 
30:978:76303:26:25:89:91:237:121:g_d0_f2:121:g_d0_f2:C: 
30:979:76304:25:26:89:91:212:121:g_d0_f2:121:g_d0_f2:C: 
30:980:76305:26:25:89:91:186:121:g_d0_f2:121:g_d0_f2:C: 
30:981:76306:25:26:89:91:161:121:g_d0_f2:121:g_d0_f2:C: 
30:982:76307:26:25:89:91:135:121:g_d0_f2:121:g_d0_f2:C: 
30:983:76308:25:25:89:91:110:121:g_d0_f2:121:g_d0_f2:C: 
30:984:76309:25:0:89:91:85:121:g_d0_f2:121:g_d0_f2:C: 
31:985:76310:0:25:163:450:709:121:g_d0_f3:121:g_d0_f2:C:Table 6b:  Unadjusted Risk Scores* by Year and Switching Status 
31:986:76374:25:25:232:381:684:121:g_d0_f3:121:g_d0_f2:C:Non‐Institutionalized, Non‐Duals 
31:987:76407:25:24:182:504:659:100:Helvetica:100:Helvetica:?: Stay in TM in next Year Switch to MA-PFFS in Next Year 
31:988:76462:24:26:189:521:635:100:Helvetica:100:Helvetica:F: N    Mean ScoreSDNMean Score SD
31:989:76493:26:25:77:521:609:100:Helvetica:121:g_d0_f3:F:2001  3,731,431  0.9220.760 596 0.8728 0.6707
31:990:76538:25:26:77:521:584:100:Helvetica:121:g_d0_f3:F:2002  3,851,378  0.9530.817 1,141 0.7611 0.6425
31:991:76585:26:25:77:521:558:100:Helvetica:121:g_d0_f3:F:2003  3,971,622  0.9760.844 4,071 0.7346 0.5912
31:992:76632:25:26:77:521:533:100:Helvetica:121:g_d0_f3:F:2004  3,927,310  0.9830.852 18,986 0.7849 0.6379
31:993:76680:26:25:77:521:507:100:Helvetica:121:g_d0_f3:F:2005  3,789,618  1.0000.868 73,088 0.8308 0.6918
31:994:76728:25:25:77:521:482:100:Helvetica:121:g_d0_f3:F:2006  3,687,693  1.0180.886 108,380 0.9416 0.8072
31:995:76777:25:26:77:521:457:100:Helvetica:121:g_d0_f3:F:2007  3,610,107  1.0230.881 85,829 0.9849 0.8379
31:996:76825:26:25:77:521:431:100:Helvetica:121:g_d0_f3:F:2008  3,531,134  1.0040.829 52,816 0.9286 0.7666
31:997:76873:25:25:77:521:406:100:Helvetica:121:g_d0_f3:F:2009  3,537,119  1.0100.838 26,502 0.9221 0.7565
31:998:76921:25:0:72:345:381:121:g_d0_f3:121:g_d0_f2:B:*Risk scores are computed using the 2007 CMS‐HCC model.   
32:999:76979:0:15:98:515:709:121:g_d0_f3:121:g_d0_f2:C:Table 7:  Outcome = Expenditures in Year T, Predictor = Fraction of Year T+1 in MA (risk score 
32:1000:77074:15:25:159:454:694:121:g_d0_f3:121:g_d0_f2:C:adjustment vs. no adjustment), Non‐Institutionalized, Non‐Duals* 
32:1001:77139:25:24:220:545:669:100:g_d0_f3:100:g_d0_f3:?:Model 1: Adjusted for Risk ScoreModel 2: Not adjusted for Risk Score
32:1002:77207:24:25:216:556:645:100:g_d0_f3:100:g_d0_f3:?:Coeff SE95%CICoeffSE 95%CI
32:1003:77233:25:14:63:179:620:100:g_d0_f3:100:g_d0_f2:?:Fraction of months in MA in 
32:1004:77261:14:0:63:376:606:100:g_d0_f3:100:g_d0_f2:?:Next Year ‐174.13 63.09 ‐297.79 ‐50.47 
32:1005:77300:0:14:419:422:620:100:g_d0_f2:100:g_d0_f2:?:‐
32:1006:77301:14:0:387:463:606:100:g_d0_f3:100:g_d0_f2:?:1,688.84 76.19 
32:1007:77316:0:14:505:508:620:100:g_d0_f2:100:g_d0_f2:?:‐
32:1008:77317:14:0:473:510:606:100:g_d0_f3:100:g_d0_f2:?:1,838.18 
32:1009:77326:0:14:553:556:620:100:g_d0_f2:100:g_d0_f2:?:‐
32:1010:77327:14:24:521:558:606:100:g_d0_f3:100:g_d0_f2:?:1,539.50 
32:1011:77336:24:14:63:84:582:100:g_d0_f3:100:g_d0_f2:?:Year 
32:1012:77341:14:0:63:136:568:100:g_d0_f3:100:g_d0_f2:?:(reference=2001) 
32:1013:77358:0:7:166:189:575:100:g_d0_f3:100:g_d0_f2:?:2002 
32:1014:77363:7:25:210:558:568:100:g_d0_f3:100:g_d0_f2:?:333.81 6.06 321.93 345.69 676.18 7.63 661.23 691.13 
32:1015:77415:25:24:63:556:543:100:g_d0_f2:100:g_d0_f3:?: 2003 441.20 6.32428.82453.581,014.928.12 999.001,030.84
32:1016:77471:24:36:63:556:519:100:g_d0_f2:100:g_d0_f3:?: 2004 660.89 6.54648.08673.701,302.568.47 1,285.971,319.16
32:1017:77529:36:0:63:65:483:100:g_d0_f2:100:g_d0_f2:?: 
32:1018:77530:0:36:166:556:495:100:g_d0_f3:100:g_d0_f3:?:2005 696.30 6.80682.98709.621,510.958.82 1,493.671,528.23
32:1019:77587:36:0:63:65:459:100:g_d0_f2:100:g_d0_f2:?: 
32:1020:77588:0:36:166:556:471:100:g_d0_f3:100:g_d0_f3:?:2006 586.26 7.18572.18600.341,591.449.41 1,572.991,609.89
32:1021:77645:36:0:63:65:435:100:g_d0_f2:100:g_d0_f2:?: 
32:1022:77646:0:36:166:556:447:100:g_d0_f3:100:g_d0_f3:?:2007 593.84 7.26579.60608.081,643.049.53 1,624.371,661.71
32:1023:77703:36:0:63:65:411:100:g_d0_f2:100:g_d0_f2:?: 
32:1024:77704:0:36:166:556:423:100:g_d0_f3:100:g_d0_f3:?:2008 798.21 7.52783.47812.951,652.439.65 1,633.511,671.35
32:1025:77761:36:0:63:65:387:100:g_d0_f2:100:g_d0_f2:?: 
32:1026:77762:0:24:166:556:399:100:g_d0_f3:100:g_d0_f3:?:2009 984.16 7.75968.96999.361,922.479.94 1,902.991,941.96
32:1027:77819:24:48:166:556:375:100:g_d0_f3:100:g_d0_f3:?:2010 1,523.65 7.851,508.261,539.052,012.329.97 1,992.772,031.87
32:1028:77882:48:14:63:152:327:100:g_d0_f3:100:g_d0_f2:?:Fraction of months in 
32:1029:77904:14:0:63:154:313:100:g_d0_f3:100:g_d0_f2:?:MA in Next Year*Year 
32:1030:77925:0:31:166:556:351:100:g_d0_f3:100:g_d0_f3:?:2002 ‐218.87 98.75‐412.41‐25.32‐549.81122.32 ‐789.55‐310.07
32:1031:77984:31:7:166:189:320:100:g_d0_f3:100:g_d0_f2:?:2003 
32:1032:77989:7:0:207:463:313:100:g_d0_f2:100:g_d0_f2:?:‐289.79 86.33 ‐458.98 ‐120.59 ‐828.00 105.29 
32:1033:78034:0:14:505:508:327:100:g_d0_f2:100:g_d0_f2:?:‐
32:1034:78035:14:24:473:558:313:100:g_d0_f3:100:g_d0_f2:?:1,034.37 ‐621.63 
32:1035:78052:24:24:63:556:289:100:g_d0_f2:100:g_d0_f3:?: 2004 ‐553.46 77.99‐706.32‐400.60‐772.5695.99 ‐960.70‐584.42
32:1036:78112:24:25:63:556:265:100:g_d0_f2:100:g_d0_f3:?: 2005 ‐513.90 68.19‐647.56‐380.25‐571.2382.88 ‐733.67‐408.78
32:1037:78172:25:24:166:556:240:100:g_d0_f3:100:g_d0_f3:?:2006 ‐34.95 68.20‐168.6298.72556.5283.47 392.91720.12
32:1038:78225:24:24:166:556:216:100:g_d0_f3:100:g_d0_f3:?:2007 ‐227.04 68.32‐360.93‐93.14589.7383.57 425.92753.53
32:1039:78280:24:24:166:556:192:100:g_d0_f3:100:g_d0_f3:?:2008 ‐147.75 69.72‐284.40‐11.09242.7984.81 76.56409.01
32:1040:78334:24:24:166:556:168:100:g_d0_f3:100:g_d0_f3:?:2009 ‐89.04 71.62‐229.4151.33501.1687.40 329.86672.47
32:1041:78387:24:24:166:556:144:100:g_d0_f3:100:g_d0_f3:?:2010 ‐231.84 71.95‐372.86‐90.82231.7287.81 59.61403.83
32:1042:78441:24:25:63:463:120:100:g_d0_f3:100:g_d0_f2:?:Risk Score (centered on 1) 10,829.92 7.6910,814.8310,845.00 
32:1043:78501:25:10:63:109:95:100:g_d0_f3:100:g_d0_f2:?:Age Group 
32:1044:78511:10:0:163:177:85:100:g_d0_f3:100:g_d0_f2:?:70‐
32:1045:78514:0:0:238:556:95:100:g_d0_f2:100:g_d0_f3:?: 1,039.198.90 1,021.751,056.63
33:1046:78544:0:38:163:176:710:100:g_d0_f3:100:g_d0_f2:?:74 
33:1047:78547:38:0:63:139:672:100:g_d0_f3:100:g_d0_f2:?:(reference=65‐69) 
33:1048:78565:0:14:163:177:686:100:g_d0_f3:100:g_d0_f2:?:75‐
33:1049:78568:14:25:163:558:672:100:g_d0_f3:100:g_d0_f2:?:79     2,198.67 10.18 2,178.72 2,218.63 
33:1050:78608:25:14:163:177:647:100:g_d0_f3:100:g_d0_f2:?:80‐
33:1051:78611:14:24:163:558:633:100:g_d0_f3:100:g_d0_f2:?:84     2,973.63 11.05 2,951.96 2,995.29 
33:1052:78651:24:14:163:177:609:100:g_d0_f3:100:g_d0_f2:?:85‐
33:1053:78654:14:24:163:558:595:100:g_d0_f3:100:g_d0_f2:?:89     3,449.23 13.09 3,423.57 3,474.90 
33:1054:78694:24:14:163:177:571:100:g_d0_f3:100:g_d0_f2:?:90‐
33:1055:78697:14:24:163:558:557:100:g_d0_f3:100:g_d0_f2:?:94     3,628.99 18.36 3,593.01 3,664.98 
33:1056:78737:24:24:163:556:533:100:g_d0_f3:100:g_d0_f3:?:95+  3,113.5832.25 3,050.373,176.79
33:1057:78772:24:39:63:556:509:100:g_d0_f3:100:g_d0_f3:?:Male  48.4010.49 27.8368.97
33:1058:78799:39:0:63:134:470:100:g_d0_f3:100:g_d0_f2:?:Male*Age Group 
33:1059:78814:0:14:163:177:484:100:g_d0_f3:100:g_d0_f2:?:70‐
33:1060:78817:14:24:163:558:470:100:g_d0_f3:100:g_d0_f2:?:74     325.25 13.90 298.00 352.49 
33:1061:78851:24:14:163:177:446:100:g_d0_f3:100:g_d0_f2:?:75‐
33:1062:78854:14:24:163:558:432:100:g_d0_f3:100:g_d0_f2:?:79     819.12 16.26 787.26 850.98 
33:1063:78888:24:14:163:177:408:100:g_d0_f3:100:g_d0_f2:?:80‐
33:1064:78891:14:24:163:558:394:100:g_d0_f3:100:g_d0_f2:?:84     1,123.17 18.35 1,087.21 1,159.13 
33:1065:78931:24:14:163:177:370:100:g_d0_f3:100:g_d0_f2:?:85‐
33:1066:78934:14:24:163:558:356:100:g_d0_f3:100:g_d0_f2:?:89     1,225.91 22.44 1,181.94 1,269.88 
33:1067:78974:24:14:163:177:332:100:g_d0_f3:100:g_d0_f2:?:90‐
33:1068:78977:14:24:163:558:318:100:g_d0_f3:100:g_d0_f2:?:94     1,143.91 33.94 1,077.40 1,210.43 
33:1069:79017:24:25:163:556:294:100:g_d0_f3:100:g_d0_f3:?:95+  1,427.1668.08 1,293.721,560.60
33:1070:79052:25:25:63:556:269:100:g_d0_f3:100:g_d0_f3:?:Constant 6,174.42 4.696,165.226,183.623,215.428.52 3,198.723,232.12
33:1071:79119:25:0:27:224:244:121:g_d0_f2:121:g_d0_f3:C:           *The sample is the same as in Table 2.
34:1072:79168:0:15:27:534:709:121:g_d0_f3:121:g_d0_f2:C:Table 8:  Model Results with MA Penetration:  Outcome = Expenditures in Year T, Predictor = Fraction of Year T+1 
34:1073:79281:15:25:26:399:694:121:g_d0_f3:121:g_d0_f2:C:in MA (risk score adjustment vs. no adjustment), Non‐Institutionalized, Non‐Duals* 
34:1074:79364:25:23:230:548:669:100:Helvetica:100:Helvetica:?:Model 1: Adjusted for Risk Score Model 2: Not adjusted for Risk Score 
34:1075:79434:23:24:220:597:646:100:Helvetica:100:Helvetica:?:Coeff            SE               95%            CI               Coeff               SE            95%               CI            
34:1076:79566:24:13:63:184:622:100:Helvetica:100:Helvetica:?:Fraction of months in MA in Next 
34:1077:79599:13:0:63:658:609:100:Helvetica:100:Helvetica:?:Year                                                         -210.18                                                         63.32                                                         -334.28                                                         -86.09                                                         -1,964.87                                                         76.49                                                         -2,114.78                                                         
34:1078:80107:0:13:568:571:622:100:Helvetica:100:Helvetica:?:-
34:1079:80108:13:24:539:573:609:100:Helvetica:100:Helvetica:?:1,814.95 
34:1080:80117:24:35:63:595:585:100:Helvetica:100:Helvetica:?:Year           (reference=2001)            2002           638.70           13.66           611.93           665.48           1,622.14           17.90           1,587.06           1,657.23           
34:1081:80315:35:0:63:65:550:100:Helvetica:100:Helvetica:?: 
34:1082:80315:0:23:174:595:562:100:Helvetica:100:Helvetica:?:2003           753.38           13.65           726.62           780.13           1,966.81           17.99           1,931.54           2,002.08           
34:1083:80470:23:24:174:588:539:100:Helvetica:100:Helvetica:?:        2004        1,007.14        13.83           980.02        1,034.25          2,293.03           18.28          2,257.21        2,328.85        
34:1084:80620:24:34:174:588:515:100:Helvetica:100:Helvetica:?:        2005        1,047.99        14.29        1,019.98        1,076.01          2,529.94           18.88          2,492.94        2,566.94        
34:1085:80769:34:0:63:65:481:100:Helvetica:100:Helvetica:?: 
34:1086:80769:0:35:174:595:492:100:Helvetica:100:Helvetica:?:2006           964.23           15.21           934.41           994.04           2,680.92           20.14           2,641.45           2,720.39           
34:1087:80924:35:0:63:65:457:100:Helvetica:100:Helvetica:?: 
34:1088:80924:0:35:174:588:469:100:Helvetica:100:Helvetica:?:2007        1,018.21        15.98           986.90        1,049.52          2,745.02           21.16          2,703.55        2,786.50        
34:1089:81066:35:0:63:65:434:100:Helvetica:100:Helvetica:?: 
34:1090:81066:0:35:174:588:446:100:Helvetica:100:Helvetica:?:2008        1,287.94        16.82        1,254.97        1,320.91          2,765.90           22.00          2,722.78        2,809.03        
34:1091:81207:35:0:63:65:411:100:Helvetica:100:Helvetica:?: 
34:1092:81207:0:24:174:588:423:100:Helvetica:100:Helvetica:?:2009        1,502.92        17.61        1,468.42        1,537.43          3,038.70           22.93          2,993.76        3,083.64        
34:1093:81348:24:33:174:588:399:100:Helvetica:100:Helvetica:?:2010        2,165.28        17.69        2,130.62        2,199.95          3,163.19           22.90          3,118.30        3,208.08        
34:1094:81489:33:13:63:156:366:100:Helvetica:100:Helvetica:?:Fraction of months in MA 
34:1095:81514:13:0:63:131:353:100:Helvetica:100:Helvetica:?:in Next Year*Year 
34:1096:81532:0:23:174:590:376:100:Helvetica:100:Helvetica:?:2002         -266.21         99.04          -460.33            -72.09            -617.10         122.70            -857.59         -376.61         
34:1097:81679:23:24:174:592:353:100:Helvetica:100:Helvetica:?:2003          -308.93          86.61          -478.69          -139.17            -811.81          105.68          -1,018.93          -604.68          
34:1098:81830:24:23:174:592:329:100:Helvetica:100:Helvetica:?:          2004          -526.14          78.23          -679.47          -372.81            -641.32           96.30            -830.06          -452.58          
34:1099:81991:23:23:174:592:306:100:Helvetica:100:Helvetica:?:          2005          -480.42          68.41          -614.51          -346.33            -345.08           83.17            -508.09          -182.08          
34:1100:82152:23:23:174:599:283:100:Helvetica:100:Helvetica:?:2006             -0.69             68.41             -134.77             133.39             826.28             83.74             662.15             990.41             
34:1101:82319:23:23:174:590:260:100:Helvetica:100:Helvetica:?:2007         -181.04         68.54          -315.39            -46.70             850.10           83.87             685.72         1,014.49         
34:1102:82468:23:24:174:595:237:100:Helvetica:100:Helvetica:?:2008           -91.17           69.96           -228.28             45.94             501.91           85.11             335.09           668.72           
34:1103:82623:24:23:174:595:213:100:Helvetica:100:Helvetica:?:2009           -25.10           71.85           -165.92           115.72             757.69           87.70             585.81           929.57           
34:1104:82777:23:24:174:590:190:100:Helvetica:100:Helvetica:?:2010         -160.31         72.16          -301.74            -18.87             491.97           88.10             319.30         664.64         
34:1105:82924:24:13:63:180:166:100:Helvetica:100:Helvetica:?:MA Penetration in County (10% 
34:1106:82954:13:23:63:600:153:100:Helvetica:100:Helvetica:?:increase)             23.92             3.38             17.30             30.54             182.67             4.27             174.30             191.05             
34:1107:83121:23:14:63:130:130:100:Helvetica:100:Helvetica:?:MA Penetration in 
34:1108:83139:14:23:63:94:116:100:Helvetica:100:Helvetica:?:County  
34:1109:83147:23:0:63:123:93:100:Helvetica:100:Helvetica:?:(10% incr)*Year 
34:1110:83163:0:30:174:600:130:100:Helvetica:100:Helvetica:?:2002             25.96             4.71             16.73             35.19               26.25             5.93               14.62             37.88             
34:1111:83326:30:7:174:195:100:100:Helvetica:100:Helvetica:?:2003 
34:1112:83331:7:0:219:593:93:100:Helvetica:100:Helvetica:?:13.71          4.99          3.92             23.49          9.70             6.42          -2.88          22.28          
35:1113:83453:0:23:174:597:710:100:Helvetica:100:Helvetica:?:            2004            -21.66            5.16            -31.77            -11.55              -35.60             6.70              -48.73            -22.47            
35:1114:83626:23:23:174:597:687:100:Helvetica:100:Helvetica:?:            2005            -24.84            5.33            -35.28            -14.39              -73.33             6.90              -86.85            -59.80            
35:1115:83799:23:23:174:597:664:100:Helvetica:100:Helvetica:?:2006            -41.65            5.47            -52.36            -30.93            -142.98             7.14            -156.97            -128.98            
35:1116:83959:23:24:174:597:641:100:Helvetica:100:Helvetica:?:2007            -64.49            5.74            -75.74            -53.24            -152.11             7.46            -166.74            -137.48            
35:1117:84119:24:23:174:595:617:100:Helvetica:100:Helvetica:?:2008           -91.37           5.83           -102.81            -79.94            -157.29             7.43            -171.84           -142.73           
35:1118:84275:23:23:174:590:594:100:Helvetica:100:Helvetica:?:2009         -101.18          6.04          -113.01            -89.34            -163.35             7.65            -178.35         -148.35         
35:1119:84424:23:24:174:592:571:100:Helvetica:100:Helvetica:?:2010          -156.00          5.96          -167.69          -144.31            -179.84             7.52            -194.58          -165.11          
35:1120:84575:24:23:63:595:547:100:Helvetica:100:Helvetica:?:Moved           334.30           11.51           311.75           356.85             961.84           15.32             931.80           991.87           
35:1121:84729:23:24:63:572:524:100:Helvetica:100:Helvetica:?:Risk Score (centered on 1) 10,829.43 7.70 10,814.35 10,844.51     
35:1122:84791:24:23:63:592:500:100:Helvetica:100:Helvetica:?:Age Group 70-74             1,043.19            8.90         1,025.75         1,060.63         
35:1123:84883:23:23:63:592:477:100:Helvetica:100:Helvetica:?:(reference=65-69)               75-79                           2,196.12          10.18         2,176.17         2,216.07         
35:1124:85010:23:24:163:592:454:100:Helvetica:100:Helvetica:?:80-84             2,961.12          11.05         2,939.46         2,982.77         
35:1125:85091:24:23:163:592:430:100:Helvetica:100:Helvetica:?:85-89             3,428.98          13.09         3,403.33         3,454.63         
35:1126:85172:23:23:163:592:407:100:Helvetica:100:Helvetica:?:90-94             3,604.20          18.35         3,568.24         3,640.17         
35:1127:85253:23:24:163:592:384:100:Helvetica:100:Helvetica:?:95+             3,091.45          32.22         3,028.30         3,154.61         
35:1128:85332:24:23:63:603:360:100:Helvetica:100:Helvetica:?:Male                  44.28              10.50              23.71              64.85              
35:1129:85427:23:24:63:599:337:100:Helvetica:100:Helvetica:?:Male*Age Group 70-74                328.06            13.90            300.81            355.30            
35:1130:85531:24:23:163:599:313:100:Helvetica:100:Helvetica:?:75-79                826.37            16.25            794.51            858.22            
35:1131:85620:23:23:163:592:290:100:Helvetica:100:Helvetica:?:80-84             1,132.36          18.34         1,096.41         1,168.31         
35:1132:85701:23:23:163:592:267:100:Helvetica:100:Helvetica:?:85-89             1,233.97          22.42         1,190.02         1,277.92         
35:1133:85782:23:23:163:592:244:100:Helvetica:100:Helvetica:?:90-94             1,148.87          33.91         1,082.40         1,215.34         
35:1134:85863:23:24:163:592:221:100:Helvetica:100:Helvetica:?:95+             1,428.28          68.03         1,294.95         1,561.62         
35:1135:85942:24:25:63:588:197:100:Helvetica:100:Helvetica:?:Constant        5,810.87        12.97        5,785.44        5,836.29          2,034.76           18.15          1,999.18        2,070.33        
35:1136:86087:25:25:72:233:172:121:g_d0_f3:121:g_d0_f2:B:*The sample is the same as Table 2. 
35:1137:86123:25:26:71:73:147:121:g_d0_f2:121:g_d0_f2:B: 
35:1138:86124:26:25:71:73:121:121:g_d0_f2:121:g_d0_f2:B: 
35:1139:86125:25:0:71:359:96:121:g_d0_f2:121:g_d0_f2:B:  
36:1140:86127:0:25:98:518:709:121:g_d0_f3:121:g_d0_f2:A:Table 9:  Outcome = Expenditures in Year T, Predictor = Fraction of Year T+1 in MA (risk score  
36:1141:86223:25:25:90:523:684:121:g_d0_f3:121:g_d0_f2:A:adjustment vs. no adjustment), Non‐Institutionalized, Non‐Duals Switching to HMO’s and PPO’s* 
36:1142:86317:25:23:224:534:659:100:Helvetica:100:Helvetica:?:Model 1: Adjusted for Risk Score Model 2: Not adjusted for Risk Score 
36:1143:86387:23:24:217:573:636:100:Helvetica:100:Helvetica:?:Coeff          SE          95%          CI            Coeff            SE              95%          CI          
36:1144:86499:24:13:63:184:612:100:Helvetica:100:Helvetica:?:Fraction of months in MA in Next 
36:1145:86532:13:24:63:564:599:100:Helvetica:100:Helvetica:?:Year      -196.69      63.32          -320.80      -72.58      -1,704.53        76.56      -1,854.58      -1,554.48      
36:1146:86653:24:23:63:575:575:100:Helvetica:100:Helvetica:?:Year           (reference=2001)           2002           337.20           6.06           325.31           349.09           676.46           7.63           661.50           691.41           
36:1147:86842:23:23:168:575:552:100:Helvetica:100:Helvetica:?:           2003           446.83           6.32           434.45           459.22           1,016.29           8.12           1,000.36           1,032.21           
36:1148:87006:23:35:168:575:529:100:Helvetica:100:Helvetica:?:           2004           667.62           6.54           654.80           680.44           1,305.89           8.47           1,289.29           1,322.49           
36:1149:87170:35:0:63:65:494:100:Helvetica:100:Helvetica:?: 
36:1150:87170:0:34:168:575:505:100:Helvetica:100:Helvetica:?:2005           704.61           6.80           691.29           717.94           1,514.82           8.82           1,497.53           1,532.11           
36:1151:87323:34:0:63:65:471:100:Helvetica:100:Helvetica:?: 
36:1152:87323:0:35:168:575:482:100:Helvetica:100:Helvetica:?:2006           597.28           7.18           583.20           611.36           1,594.98           9.42           1,576.52           1,613.43           
36:1153:87476:35:0:63:65:447:100:Helvetica:100:Helvetica:?: 
36:1154:87476:0:35:168:575:459:100:Helvetica:100:Helvetica:?:2007           604.86           7.26           590.63           619.10           1,645.76           9.53           1,627.09           1,664.44           
36:1155:87629:35:0:63:65:424:100:Helvetica:100:Helvetica:?: 
36:1156:87629:0:35:168:575:436:100:Helvetica:100:Helvetica:?:2008           807.31           7.52           792.57           822.06           1,654.99           9.66           1,636.06           1,673.91           
36:1157:87782:35:0:63:65:401:100:Helvetica:100:Helvetica:?: 
36:1158:87782:0:24:168:575:413:100:Helvetica:100:Helvetica:?:2009           993.77           7.77           978.54           1,009.00           1,924.48           9.94           1,904.99           1,943.96           
36:1159:87937:24:13:63:142:389:100:Helvetica:100:Helvetica:?:Fraction of months in 
36:1160:87959:13:23:63:80:376:100:Helvetica:100:Helvetica:?:MA  
36:1161:87963:23:0:63:113:353:100:Helvetica:100:Helvetica:?:in Next Yr*Yr 
36:1162:87977:0:30:168:572:389:100:Helvetica:100:Helvetica:?:2002          -211.06          99.51          -406.10            -16.02          -507.30          123.54          -749.43          -265.17          
36:1163:88125:30:30:168:563:359:100:Helvetica:100:Helvetica:?:2003 -355.56      88.45          -528.92          -182.20         -808.93      108.16      -1,020.92         -596.93      
36:1164:88247:30:23:168:572:329:100:Helvetica:100:Helvetica:?:          2004          -659.68          81.88          -820.16          -499.19          -585.88          101.25          -784.33          -387.43          
36:1165:88404:23:23:168:572:306:100:Helvetica:100:Helvetica:?:          2005          -683.76          72.11          -825.10          -542.42          -486.88          87.82          -659.01          -314.76          
36:1166:88560:23:23:168:572:283:100:Helvetica:100:Helvetica:?:2006          -196.44          76.14          -345.67            -47.21           -55.24          94.60          -240.65           130.17          
36:1167:88707:23:23:168:572:260:100:Helvetica:100:Helvetica:?:2007          -155.84          73.67          -300.22            -11.45           194.29          90.71            16.50           372.08          
36:1168:88854:23:24:168:572:237:100:Helvetica:100:Helvetica:?:2008          -228.47          73.21          -371.97            -84.98          -160.82          89.11          -335.47            13.84          
36:1169:89001:24:23:168:572:213:100:Helvetica:100:Helvetica:?:2009          -120.70          74.07          -265.87             24.47           390.32          90.71           212.54           568.10          
36:1170:89148:23:24:63:553:190:100:Helvetica:100:Helvetica:?:Risk Score (centered on 1) 10,724.59 7.93 10,709.06 10,740.13     
36:1171:89210:24:23:63:566:166:100:Helvetica:100:Helvetica:?:Age Group 70-74           1,023.49          9.34       1,005.20       1,041.79       
36:1172:89292:23:23:63:566:143:100:Helvetica:100:Helvetica:?:(reference=65-69)               75-79                         2,161.12        10.55       2,140.44       2,181.81       
36:1173:89409:23:24:163:566:120:100:Helvetica:100:Helvetica:?:80-84           2,904.99        11.43       2,882.59       2,927.38       
36:1174:89480:24:0:163:566:96:100:Helvetica:100:Helvetica:?:85-89           3,344.25        13.52       3,317.74       3,370.75       
37:1175:89551:0:23:163:566:710:100:Helvetica:100:Helvetica:?:90-94           3,485.41        18.98       3,448.22       3,522.61       
37:1176:89622:23:24:163:566:687:100:Helvetica:100:Helvetica:?:95+           2,966.50        33.10       2,901.63       3,031.38       
37:1177:89691:24:24:63:578:663:100:Helvetica:100:Helvetica:?:Male                67.11            11.01            45.53            88.69            
37:1178:89776:24:23:63:573:639:100:Helvetica:100:Helvetica:?:Male*Age Group 70-74              327.83          14.62          299.18          356.48          
37:1179:89870:23:23:163:573:616:100:Helvetica:100:Helvetica:?:75-79              830.72          16.90          797.60          863.85          
37:1180:89949:23:23:163:566:593:100:Helvetica:100:Helvetica:?:80-84           1,132.71        18.97       1,095.54       1,169.89       
37:1181:90020:23:24:163:566:570:100:Helvetica:100:Helvetica:?:85-89           1,235.56        23.27       1,189.95       1,281.17       
37:1182:90091:24:23:163:566:546:100:Helvetica:100:Helvetica:?:90-94           1,142.96        35.21       1,073.94       1,211.98       
37:1183:90162:23:24:163:566:523:100:Helvetica:100:Helvetica:?:95+           1,357.56        70.25       1,219.87       1,495.25       
37:1184:90231:24:24:63:568:499:100:Helvetica:100:Helvetica:?:Constant        6,166.15        4.70        6,156.93        6,175.36        3,246.75          8.72        3,229.67        3,263.84        
37:1185:90369:24:0:72:244:475:121:g_d0_f3:121:g_d0_f2:B:*The sample is the same as in Table 5. 
38:1186:90408:0:26:149:464:709:121:g_d0_f3:121:g_d0_f2:C:Table 10:  Mean number of providers seen in 2011 by number of HCCs 
38:1187:90475:26:26:115:494:683:121:g_d0_f3:121:g_d0_f2:C:No. of HCCs SubjectsMean No. of Providers SD Min Max 
38:1188:90528:26:25:144:490:657:121:g_d0_f3:121:g_d0_f2:A:0  1,642,618 3.50 3.74 0 90 
38:1189:90556:25:26:144:493:632:121:g_d0_f3:121:g_d0_f2:A:1  1,091,932 5.38 4.48 0 101 
38:1190:90585:26:25:144:493:606:121:g_d0_f3:121:g_d0_f2:A:2  633,884 6.74 5.33 0 104 
38:1191:90612:25:26:144:493:581:121:g_d0_f3:121:g_d0_f2:A:3  346,879 8.00 6.18 0 101 
38:1192:90639:26:26:144:493:555:121:g_d0_f3:121:g_d0_f2:A:4  406,325 10.55 8.31 0 225 
38:1193:90667:26:15:108:525:529:121:g_d0_f3:121:g_d0_f2:A:Source: 2011 20% Medicare claims sample and the Carrier file.  Providers include MD’s, DO’s, 
38:1194:90760:15:15:107:523:514:121:g_d0_f3:121:g_d0_f2:A:and RN’s billing independently other than radiologists, anesthesiologists, and pathologists as 
38:1195:90855:15:16:107:532:499:121:g_d0_f3:121:g_d0_f2:A:identified from the provider specialty variable on the Carrier file.  All differences are significant 
38:1196:90957:16:25:107:195:483:121:g_d0_f3:121:g_d0_f2:A:at the 0.0001 level. 
38:1197:90978:25:26:71:73:458:121:g_d0_f2:121:g_d0_f2:B: 
38:1198:90979:26:0:71:73:432:121:g_d0_f2:121:g_d0_f2:B: 
